{ "instance": { "trhc-20220930x10q.htm": { "axisCustom": 0, "axisStandard": 34, "contextCount": 364, "dts": { "calculationLink": { "local": [ "trhc-20220930_cal.xml" ] }, "definitionLink": { "local": [ "trhc-20220930_def.xml" ] }, "inline": { "local": [ "trhc-20220930x10q.htm" ] }, "labelLink": { "local": [ "trhc-20220930_lab.xml" ] }, "presentationLink": { "local": [ "trhc-20220930_pre.xml" ] }, "schema": { "local": [ "trhc-20220930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 675, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 54, "http://www.tabularasahealthcare.com/20220930": 3, "http://xbrl.sec.gov/dei/2022": 5, "total": 62 }, "keyCustom": 101, "keyStandard": 304, "memberCustom": 58, "memberStandard": 37, "nsprefix": "trhc", "nsuri": "http://www.tabularasahealthcare.com/20220930", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00090 - Document - Document and Entity Information", "role": "http://www.tabularasahealthcare.com/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10301 - Disclosure - Discontinued Operations", "role": "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperations", "shortName": "Discontinued Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10401 - Disclosure - Revenue", "role": "http://www.tabularasahealthcare.com/role/DisclosureRevenue", "shortName": "Revenue", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10501 - Disclosure - Net Loss per Share", "role": "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShare", "shortName": "Net Loss per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCurrentAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10601 - Disclosure - Other Current Assets", "role": "http://www.tabularasahealthcare.com/role/DisclosureOtherCurrentAssets", "shortName": "Other Current Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCurrentAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10701 - Disclosure - Property and Equipment", "role": "http://www.tabularasahealthcare.com/role/DisclosurePropertyAndEquipment", "shortName": "Property and Equipment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10801 - Disclosure - Software Development Costs", "role": "http://www.tabularasahealthcare.com/role/DisclosureSoftwareDevelopmentCosts", "shortName": "Software Development Costs", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10901 - Disclosure - Goodwill and Intangible Assets", "role": "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssets", "shortName": "Goodwill and Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11001 - Disclosure - Accrued Expenses and Other Liabilities", "role": "http://www.tabularasahealthcare.com/role/DisclosureAccruedExpensesAndOtherLiabilities", "shortName": "Accrued Expenses and Other Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11101 - Disclosure - Line of Credit and Long-Term Debt", "role": "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebt", "shortName": "Line of Credit and Long-Term Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11201 - Disclosure - Income Taxes", "role": "http://www.tabularasahealthcare.com/role/DisclosureIncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_NKZrGXZuwEyuDZrcvJIJzw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00100 - Statement - CONSOLIDATED BALANCE SHEETS", "role": "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets", "shortName": "CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_12_31_2021__yQBd86kq0K8_fIeH_JXOQ", "decimals": "-3", "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11301 - Disclosure - Stock-Based Compensation", "role": "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensation", "shortName": "Stock-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11401 - Disclosure - Fair Value Measurements", "role": "http://www.tabularasahealthcare.com/role/DisclosureFairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11501 - Disclosure - Commitments and Contingencies", "role": "http://www.tabularasahealthcare.com/role/DisclosureCommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11601 - Disclosure - Segment Reporting", "role": "http://www.tabularasahealthcare.com/role/DisclosureSegmentReporting", "shortName": "Segment Reporting", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11701 - Disclosure - Related Party Transactions", "role": "http://www.tabularasahealthcare.com/role/DisclosureRelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "trhc:RightsAgreementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11801 - Disclosure - Rights Plan", "role": "http://www.tabularasahealthcare.com/role/DisclosureRightsPlan", "shortName": "Rights Plan", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "trhc:RightsAgreementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "20202 - Disclosure - Basis of Presentation, Summary of Significant Accounting Policies, and Recent Accounting Pronouncements (Policies)", "role": "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies", "shortName": "Basis of Presentation, Summary of Significant Accounting Policies, and Recent Accounting Pronouncements (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_us-gaap_DisposalGroupClassificationAxis_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_trhc_PrescribewellnessBusinessMember_Fzi0dhzjIke4nV24IrVn0w", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30303 - Disclosure - Discontinued Operations (Tables)", "role": "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsTables", "shortName": "Discontinued Operations (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_us-gaap_DisposalGroupClassificationAxis_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_trhc_PrescribewellnessBusinessMember_Fzi0dhzjIke4nV24IrVn0w", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30403 - Disclosure - Revenue (Tables)", "role": "http://www.tabularasahealthcare.com/role/DisclosureRevenueTables", "shortName": "Revenue (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30503 - Disclosure - Net Loss per Share (Tables)", "role": "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareTables", "shortName": "Net Loss per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_NKZrGXZuwEyuDZrcvJIJzw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00105 - Statement - CONSOLIDATED BALANCE SHEETS (parenthetical)", "role": "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheetsParenthetical", "shortName": "CONSOLIDATED BALANCE SHEETS (parenthetical)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_NKZrGXZuwEyuDZrcvJIJzw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:OtherCurrentAssetsTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30603 - Disclosure - Other Current Assets (Tables)", "role": "http://www.tabularasahealthcare.com/role/DisclosureOtherCurrentAssetsTables", "shortName": "Other Current Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:OtherCurrentAssetsTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "trhc:ResearchDevelopmentAndComputerSoftwareTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30803 - Disclosure - Software Development Costs (Tables)", "role": "http://www.tabularasahealthcare.com/role/DisclosureSoftwareDevelopmentCostsTables", "shortName": "Software Development Costs (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "trhc:ResearchDevelopmentAndComputerSoftwareTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30903 - Disclosure - Goodwill and Intangible Assets (Tables)", "role": "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsTables", "shortName": "Goodwill and Intangible Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "trhc:ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "31003 - Disclosure - Accrued Expenses and Other Liabilities (Tables)", "role": "http://www.tabularasahealthcare.com/role/DisclosureAccruedExpensesAndOtherLiabilitiesTables", "shortName": "Accrued Expenses and Other Liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "trhc:ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "31103 - Disclosure - Line of Credit and Long-Term Debt (Tables)", "role": "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtTables", "shortName": "Line of Credit and Long-Term Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "31303 - Disclosure - Stock-Based Compensation (Tables)", "role": "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationTables", "shortName": "Stock-Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "31403 - Disclosure - Fair Value Measurements (Tables)", "role": "http://www.tabularasahealthcare.com/role/DisclosureFairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "31603 - Disclosure - Segment Reporting (Tables)", "role": "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingTables", "shortName": "Segment Reporting (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "p", "trhc:CloudComputingArrangementsPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_NKZrGXZuwEyuDZrcvJIJzw", "decimals": "-3", "first": true, "lang": null, "name": "trhc:AccumulatedAmortizationCloudComputingImplementationCosts", "reportCount": 1, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40201 - Disclosure - Basis of Presentation, Summary of Significant Accounting Policies, and Recent Accounting Pronouncements - Cloud Computing Arrangements (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsCloudComputingArrangementsDetails", "shortName": "Basis of Presentation, Summary of Significant Accounting Policies, and Recent Accounting Pronouncements - Cloud Computing Arrangements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "trhc:CloudComputingArrangementsPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_12_31_2021__yQBd86kq0K8_fIeH_JXOQ", "decimals": "-3", "lang": null, "name": "trhc:AccumulatedAmortizationCloudComputingImplementationCosts", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "p", "trhc:VendorFinancingArrangementsPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_2_24_2022_srt_CounterpartyNameAxis_trhc_BusinessProcessSupportAndTechnologyServicesPartnerMember_NeDf6yTpV0iaWBZTc0TRjA", "decimals": "-1", "first": true, "lang": null, "name": "trhc:BusinessPartnershipAgreementNumberOfEmployeesHiredByThirdPartyProvider", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_employee_8Q4pZNiPnESkxU0P46N_Lg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40202 - Disclosure - Basis of Presentation, Summary of Significant Accounting Policies, and Recent Accounting Pronouncements - Vendor Financing Arrangements (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsVendorFinancingArrangementsDetails", "shortName": "Basis of Presentation, Summary of Significant Accounting Policies, and Recent Accounting Pronouncements - Vendor Financing Arrangements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "trhc:VendorFinancingArrangementsPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_2_24_2022_srt_CounterpartyNameAxis_trhc_BusinessProcessSupportAndTechnologyServicesPartnerMember_NeDf6yTpV0iaWBZTc0TRjA", "decimals": "-1", "first": true, "lang": null, "name": "trhc:BusinessPartnershipAgreementNumberOfEmployeesHiredByThirdPartyProvider", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_employee_8Q4pZNiPnESkxU0P46N_Lg", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_88PaZddhkkCd7Rqlu4UDKA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS", "role": "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_88PaZddhkkCd7Rqlu4UDKA", "decimals": "-3", "lang": null, "name": "us-gaap:CostOfRevenue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "p", "us-gaap:ConcentrationRiskCreditRisk", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "trhc:TermToReceiveNonelectronicPaymentOfClaim", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40203 - Disclosure - Basis of Presentation, Summary of Significant Accounting Policies, and Recent Accounting Pronouncements - Concentrations (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsConcentrationsDetails", "shortName": "Basis of Presentation, Summary of Significant Accounting Policies, and Recent Accounting Pronouncements - Concentrations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:ConcentrationRiskCreditRisk", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "trhc:TermToReceiveNonelectronicPaymentOfClaim", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_8_1_2022_wePyvaqtR0W3Tnv43R9W0A", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationContingentConsiderationAssetNoncurrent", "reportCount": 1, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40301 - Disclosure - Discontinued Operations - Divestiture of Business (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails", "shortName": "Discontinued Operations - Divestiture of Business (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:OtherNonoperatingIncomeExpense", "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_srt_CounterpartyNameAxis_trhc_TransactionDataSystemsInc.Member_us-gaap_TypeOfArrangementAxis_trhc_TransitionServicesAgreementMember_Ag6EKdOffU6cwQDA88UntA", "decimals": "-3", "lang": null, "name": "us-gaap:OtherNonoperatingIncomeExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_NKZrGXZuwEyuDZrcvJIJzw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "reportCount": 1, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40302 - Disclosure - Discontinued Operations - Divestiture of Business, Assets and Liabilities (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "shortName": "Discontinued Operations - Divestiture of Business, Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_8_1_2022_us-gaap_DisposalGroupClassificationAxis_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_trhc_PrescribewellnessBusinessMember_0UhCasv0-UyQTHgSeruvIQ", "decimals": "-3", "lang": null, "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:GainLossOnSaleOfBusiness", "reportCount": 1, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40303 - Disclosure - Discontinued Operations - Divestiture of Business, Results of Operations (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessResultsOfOperationsDetails", "shortName": "Discontinued Operations - Divestiture of Business, Results of Operations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_us-gaap_DisposalGroupClassificationAxis_us-gaap_SegmentDiscontinuedOperationsMember_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_trhc_PrescribewellnessBusinessMember_Feq_25WxVUWhJ092LsIHww", "decimals": "-3", "lang": null, "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:GainLossOnSaleOfBusiness", "reportCount": 1, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40304 - Disclosure - Discontinued Operations - Divestiture of Business, Operating non-cash items and investing activities (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessOperatingNonCashItemsAndInvestingActivitiesDetails", "shortName": "Discontinued Operations - Divestiture of Business, Operating non-cash items and investing activities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_us-gaap_DisposalGroupClassificationAxis_us-gaap_SegmentDiscontinuedOperationsMember_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_trhc_PrescribewellnessBusinessMember_oQY9krVGOEuoSMPpYJGmPg", "decimals": "-3", "lang": null, "name": "us-gaap:DepreciationAndAmortizationDiscontinuedOperations", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested", "reportCount": 1, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40305 - Disclosure - Discontinued Operations - Held for Sale (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleDetails", "shortName": "Discontinued Operations - Held for Sale (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_trhc_DosemeAndSinfonarxBusinessesMember_M9f2i9S8ZU-3sggTDCHxQg", "decimals": null, "lang": "en-US", "name": "trhc:DiscontinuedOperationsSaleCompletionPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_88PaZddhkkCd7Rqlu4UDKA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax", "reportCount": 1, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40306 - Disclosure - Discontinued Operations - Held for Sale, Results of Operations (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleResultsOfOperationsDetails", "shortName": "Discontinued Operations - Held for Sale, Results of Operations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_us-gaap_DisposalGroupClassificationAxis_us-gaap_DiscontinuedOperationsHeldforsaleMember_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_trhc_DosemeAndSinfonarxBusinessesMember_aqLQ5o-gzECim3UZJoJPsQ", "decimals": "-3", "lang": null, "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_NKZrGXZuwEyuDZrcvJIJzw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "reportCount": 1, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40307 - Disclosure - Discontinued Operations - Held for Sale, Assets and Liabilities (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails", "shortName": "Discontinued Operations - Held for Sale, Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_us-gaap_DisposalGroupClassificationAxis_us-gaap_DiscontinuedOperationsHeldforsaleMember_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_trhc_DosemeAndSinfonarxBusinessesMember_mGpX6b8Yckum5gRsg-CsDQ", "decimals": "-3", "lang": null, "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_us-gaap_DisposalGroupClassificationAxis_us-gaap_DiscontinuedOperationsHeldforsaleMember_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_trhc_DosemeAndSinfonarxBusinessesMember_w-e0qbc6qUyzUB6jERYcjQ", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DepreciationAndAmortizationDiscontinuedOperations", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40308 - Disclosure - Discontinued Operations - Held for Sale, Operating non-cash items and investing activities (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleOperatingNonCashItemsAndInvestingActivitiesDetails", "shortName": "Discontinued Operations - Held for Sale, Operating non-cash items and investing activities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_us-gaap_DisposalGroupClassificationAxis_us-gaap_DiscontinuedOperationsHeldforsaleMember_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_trhc_DosemeAndSinfonarxBusinessesMember_w-e0qbc6qUyzUB6jERYcjQ", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DepreciationAndAmortizationDiscontinuedOperations", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_srt_RangeAxis_srt_MaximumMember_knZEsBlGqUCyhJoudeNaKw", "decimals": null, "first": true, "lang": "en-US", "name": "trhc:ContractWithCustomerTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40401 - Disclosure - Revenue - General (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureRevenueGeneralDetails", "shortName": "Revenue - General (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_srt_RangeAxis_srt_MaximumMember_knZEsBlGqUCyhJoudeNaKw", "decimals": null, "first": true, "lang": "en-US", "name": "trhc:ContractWithCustomerTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_12_31_2020_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_xSvF8l6CT0SZ_sYFoxMQ-A", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00300 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)", "role": "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit", "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2021_To_3_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_ZkvkPWeh-0-NKubBKxDY5w", "decimals": "INF", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_L4aHSyKQEkyVOLJnRUzxsg", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_88PaZddhkkCd7Rqlu4UDKA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40402 - Disclosure - Revenue - Disaggregation (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureRevenueDisaggregationDetails", "shortName": "Revenue - Disaggregation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_srt_ProductOrServiceAxis_trhc_PaceProductMember_us-gaap_StatementBusinessSegmentsAxis_trhc_CareventionHealthcareMember_mQfQlCumkUSqYuh_ia4jJA", "decimals": "-3", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "trhc:ContractWithCustomerAssetAndLiabilityAndReceivablesBalancesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_NKZrGXZuwEyuDZrcvJIJzw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerAssetNetCurrent", "reportCount": 1, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40403 - Disclosure - Revenue - Contract Balances (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureRevenueContractBalancesDetails", "shortName": "Revenue - Contract Balances (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R52": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "trhc:ContractWithCustomerAssetAndLiabilityAndReceivablesBalancesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_12_31_2021__yQBd86kq0K8_fIeH_JXOQ", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerAssetNetCurrent", "reportCount": 1, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40404 - Disclosure - Revenue - Change in contract balances (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureRevenueChangeInContractBalancesDetails", "shortName": "Revenue - Change in contract balances (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "trhc:ContractWithCustomerAssetAndLiabilityChangesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": "-3", "lang": null, "name": "trhc:ContractWithCustomerAssetCashReceived", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_88PaZddhkkCd7Rqlu4UDKA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40501 - Disclosure - Net Loss per Share - EPS (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareEpsDetails", "shortName": "Net Loss per Share - EPS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_88PaZddhkkCd7Rqlu4UDKA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_L4aHSyKQEkyVOLJnRUzxsg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40502 - Disclosure - Net Loss per Share - Anti-dilutive Securities (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareAntiDilutiveSecuritiesDetails", "shortName": "Net Loss per Share - Anti-dilutive Securities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_L4aHSyKQEkyVOLJnRUzxsg", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "trhc:ContractWithCustomerAssetAndLiabilityAndReceivablesBalancesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_NKZrGXZuwEyuDZrcvJIJzw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerAssetNetCurrent", "reportCount": 1, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40601 - Disclosure - Other Current Assets (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureOtherCurrentAssetsDetails", "shortName": "Other Current Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "us-gaap:OtherCurrentAssetsTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_NKZrGXZuwEyuDZrcvJIJzw", "decimals": "-3", "lang": null, "name": "us-gaap:NontradeReceivablesCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_NKZrGXZuwEyuDZrcvJIJzw", "decimals": "-3", "first": true, "lang": null, "name": "trhc:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetExcludingComputerSoftwareDevelopmentCostAfterAccumulatedDepreciationAndAmortization", "reportCount": 1, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40701 - Disclosure - Property and Equipment (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosurePropertyAndEquipmentDetails", "shortName": "Property and Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_12_31_2021_us-gaap_PropertyPlantAndEquipmentByTypeAxis_trhc_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetExcludingComputerSoftwareDevelopmentCostMember_P6R0bISQc0SpYOVIRmxNPQ", "decimals": "-3", "lang": null, "name": "trhc:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetExcludingComputerSoftwareDevelopmentCostAccumulatedDepreciationAndAmortization", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "trhc:ResearchDevelopmentAndComputerSoftwareTableTextBlock", "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_NKZrGXZuwEyuDZrcvJIJzw", "decimals": "-3", "first": true, "lang": null, "name": "trhc:CapitalizedSoftwareDevelopmentCostsGross", "reportCount": 1, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40801 - Disclosure - Software Development Costs (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureSoftwareDevelopmentCostsDetails", "shortName": "Software Development Costs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "trhc:ResearchDevelopmentAndComputerSoftwareTableTextBlock", "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_12_31_2021__yQBd86kq0K8_fIeH_JXOQ", "decimals": "-3", "lang": null, "name": "trhc:CapitalizedSoftwareDevelopmentCostsGross", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_NKZrGXZuwEyuDZrcvJIJzw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40901 - Disclosure - Goodwill and Intangible Assets - Goodwill (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsGoodwillDetails", "shortName": "Goodwill and Intangible Assets - Goodwill (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R59": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_NKZrGXZuwEyuDZrcvJIJzw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40902 - Disclosure - Goodwill and Intangible Assets - Intangible assets (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsIntangibleAssetsDetails", "shortName": "Goodwill and Intangible Assets - Intangible assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_12_31_2021__yQBd86kq0K8_fIeH_JXOQ", "decimals": "-3", "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00400 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "role": "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_NKZrGXZuwEyuDZrcvJIJzw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40903 - Disclosure - Goodwill and Intangible Assets - Amortization (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsAmortizationDetails", "shortName": "Goodwill and Intangible Assets - Amortization (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_NKZrGXZuwEyuDZrcvJIJzw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "trhc:ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_NKZrGXZuwEyuDZrcvJIJzw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41001 - Disclosure - Accrued Expenses and Other Liabilities (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureAccruedExpensesAndOtherLiabilitiesDetails", "shortName": "Accrued Expenses and Other Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "trhc:ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_NKZrGXZuwEyuDZrcvJIJzw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RepaymentsOfLinesOfCredit", "reportCount": 1, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41101 - Disclosure - Line of Credit and Long-Term Debt - Line of Credit (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLineOfCreditDetails", "shortName": "Line of Credit and Long-Term Debt - Line of Credit (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:DebtDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_12_18_2020_us-gaap_DebtInstrumentAxis_trhc_LoanAndSecurityAgreement2020Member_a41iDj3HS0G6L_f7nTsD3g", "decimals": "-3", "lang": null, "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "trhc:ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_NKZrGXZuwEyuDZrcvJIJzw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InterestPayableCurrent", "reportCount": 1, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41102 - Disclosure - Line of Credit and Long-Term Debt - Convertible Senior Subordinated Notes (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleSeniorSubordinatedNotesDetails", "shortName": "Line of Credit and Long-Term Debt - Convertible Senior Subordinated Notes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_2_12_2019_To_2_12_2019_us-gaap_DebtInstrumentAxis_trhc_ConvertibleSeniorSubordinatedNotesMember_KlVlEDVkw0yHHXjSWzy88g", "decimals": "7", "lang": null, "name": "us-gaap:DebtInstrumentConvertibleConversionRatio1", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_0bHfwAQdpEGcu88Hhu8AoA", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": "INF", "first": true, "lang": null, "name": "trhc:WarrantsExercisesInPeriod", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_L4aHSyKQEkyVOLJnRUzxsg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41103 - Disclosure - Line of Credit and Long-Term Debt - Convertible Note Hedge and Warrant Transactions (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleNoteHedgeAndWarrantTransactionsDetails", "shortName": "Line of Credit and Long-Term Debt - Convertible Note Hedge and Warrant Transactions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": "INF", "first": true, "lang": null, "name": "trhc:WarrantsExercisesInPeriod", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_L4aHSyKQEkyVOLJnRUzxsg", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_NKZrGXZuwEyuDZrcvJIJzw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41104 - Disclosure - Line of Credit and Long-Term Debt - Long-term debt (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLongTermDebtDetails", "shortName": "Line of Credit and Long-Term Debt - Long-term debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_NKZrGXZuwEyuDZrcvJIJzw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_88PaZddhkkCd7Rqlu4UDKA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeTaxExpenseBenefit", "reportCount": 1, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41201 - Disclosure - Income Taxes (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureIncomeTaxesDetails", "shortName": "Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_88PaZddhkkCd7Rqlu4UDKA", "decimals": "3", "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_0bHfwAQdpEGcu88Hhu8AoA", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_9_1_2016_To_9_30_2016_us-gaap_PlanNameAxis_trhc_EquityCompensationPlan2016Member_aMR51WcXtEiOYjU1p9O5Jw", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_0bHfwAQdpEGcu88Hhu8AoA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41301 - Disclosure - Stock-Based Compensation - Plans (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPlansDetails", "shortName": "Stock-Based Compensation - Plans (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_9_1_2016_To_9_30_2016_us-gaap_PlanNameAxis_trhc_EquityCompensationPlan2016Member_aMR51WcXtEiOYjU1p9O5Jw", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_0bHfwAQdpEGcu88Hhu8AoA", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_88PaZddhkkCd7Rqlu4UDKA", "decimals": "-3", "first": true, "lang": null, "name": "trhc:ShareBasedPaymentArrangementExpenseIncludingDiscontinuedOperations", "reportCount": 1, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41302 - Disclosure - Stock-Based Compensation - Restricted Common Stock and Restricted Stock Units (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationRestrictedCommonStockAndRestrictedStockUnitsDetails", "shortName": "Stock-Based Compensation - Restricted Common Stock and Restricted Stock Units (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_us-gaap_AwardTypeAxis_trhc_RestrictedStockAndRestrictedStockUnitsMember_g2DmFKA_ikyDR5bK46es0A", "decimals": "-3", "lang": null, "name": "trhc:ShareBasedPaymentArrangementExpenseIncludingDiscontinuedOperations", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_88PaZddhkkCd7Rqlu4UDKA", "decimals": "-3", "first": true, "lang": null, "name": "trhc:ShareBasedPaymentArrangementExpenseIncludingDiscontinuedOperations", "reportCount": 1, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41303 - Disclosure - Stock-Based Compensation - Performance Based Equity Awards (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPerformanceBasedEquityAwardsDetails", "shortName": "Stock-Based Compensation - Performance Based Equity Awards (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_10_29_2020_To_10_29_2020_us-gaap_AwardDateAxis_trhc_AwardDate29october2020Member_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_5BCGeY0r6EuGJWNe9FQJqw", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_L4aHSyKQEkyVOLJnRUzxsg", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_NKZrGXZuwEyuDZrcvJIJzw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00405 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)", "role": "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlowsParenthetical", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_9_30_2021_l8oHgu_dTEiYlxZIThSlQg", "decimals": "-3", "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_88PaZddhkkCd7Rqlu4UDKA", "decimals": "-3", "first": true, "lang": null, "name": "trhc:ShareBasedPaymentArrangementExpenseIncludingDiscontinuedOperations", "reportCount": 1, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41304 - Disclosure - Stock-Based Compensation - Other Stock Awards (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOtherStockAwardsDetails", "shortName": "Stock-Based Compensation - Other Stock Awards (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2021_To_3_31_2021_us-gaap_AwardDateAxis_trhc_AwardDateFirstQuarter2021Member_us-gaap_AwardTypeAxis_trhc_StockAwardMember_u23tilsWFkyV4wq4uyGgbA", "decimals": "INF", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_L4aHSyKQEkyVOLJnRUzxsg", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_88PaZddhkkCd7Rqlu4UDKA", "decimals": "-3", "first": true, "lang": null, "name": "trhc:ShareBasedPaymentArrangementExpenseIncludingDiscontinuedOperations", "reportCount": 1, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41305 - Disclosure - Stock-Based Compensation - Options Valuation (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsValuationDetails", "shortName": "Stock-Based Compensation - Options Valuation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_L4aHSyKQEkyVOLJnRUzxsg", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_12_31_2021__yQBd86kq0K8_fIeH_JXOQ", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_L4aHSyKQEkyVOLJnRUzxsg", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41306 - Disclosure - Stock-Based Compensation - Options Activity (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsActivityDetails", "shortName": "Stock-Based Compensation - Options Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_12_31_2021__yQBd86kq0K8_fIeH_JXOQ", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_L4aHSyKQEkyVOLJnRUzxsg", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_88PaZddhkkCd7Rqlu4UDKA", "decimals": "-3", "first": true, "lang": null, "name": "trhc:ShareBasedPaymentArrangementExpenseIncludingDiscontinuedOperations", "reportCount": 1, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41307 - Disclosure - Stock-Based Compensation - Expense (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationExpenseDetails", "shortName": "Stock-Based Compensation - Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_us-gaap_IncomeStatementLocationAxis_trhc_CostOfProductRevenueMember_vURxbuKEEkCy3VWdqu4B5A", "decimals": "-3", "lang": null, "name": "trhc:ShareBasedPaymentArrangementExpenseIncludingDiscontinuedOperations", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockMember_mW5XMNI55U-Ll67jCDno-A", "decimals": "INF", "first": true, "lang": null, "name": "trhc:ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfCommonStockDiscount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_0bHfwAQdpEGcu88Hhu8AoA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41308 - Disclosure - Stock-Based Compensation - Employee Stock Purchase Plan (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationEmployeeStockPurchasePlanDetails", "shortName": "Stock-Based Compensation - Employee Stock Purchase Plan (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockMember_mW5XMNI55U-Ll67jCDno-A", "decimals": "INF", "first": true, "lang": null, "name": "trhc:ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfCommonStockDiscount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_0bHfwAQdpEGcu88Hhu8AoA", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_NKZrGXZuwEyuDZrcvJIJzw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationContingentConsiderationAssetNoncurrent", "reportCount": 1, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41401 - Disclosure - Fair Value Measurements - Financial Instruments (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureFairValueMeasurementsFinancialInstrumentsDetails", "shortName": "Fair Value Measurements - Financial Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_Iuun1rKJE0-aZN9_Zw6vvA", "decimals": "-3", "lang": null, "name": "us-gaap:BusinessCombinationContingentConsiderationAssetNoncurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_3_29_2019_To_3_29_2019_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_trhc_ThriftyDrugStoresInc.Member_bhGsP-wBT0GSKCQwlXTU3g", "decimals": "2", "first": true, "lang": null, "name": "trhc:PurchaseObligationMinimumAmountPercent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_0bHfwAQdpEGcu88Hhu8AoA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41501 - Disclosure - Commitments and Contingencies - Vendor Purchase Agreements (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureCommitmentsAndContingenciesVendorPurchaseAgreementsDetails", "shortName": "Commitments and Contingencies - Vendor Purchase Agreements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_3_29_2019_To_3_29_2019_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_trhc_ThriftyDrugStoresInc.Member_bhGsP-wBT0GSKCQwlXTU3g", "decimals": "2", "first": true, "lang": null, "name": "trhc:PurchaseObligationMinimumAmountPercent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_0bHfwAQdpEGcu88Hhu8AoA", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_segment__KzL24mRLU6ZyZmUt6ySwQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41601 - Disclosure - Segment Reporting - Revenue (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingRevenueDetails", "shortName": "Segment Reporting - Revenue (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_segment__KzL24mRLU6ZyZmUt6ySwQ", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_88PaZddhkkCd7Rqlu4UDKA", "decimals": "-3", "first": true, "lang": null, "name": "trhc:AdjustedEbitdaContinuingOperations", "reportCount": 1, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41602 - Disclosure - Segment Reporting - EBITDA (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingEbitdaDetails", "shortName": "Segment Reporting - EBITDA (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_srt_ConsolidationItemsAxis_us-gaap_CorporateNonSegmentMember_dtu_aGokJUqjc4cCJ9YZpA", "decimals": "-3", "lang": null, "name": "trhc:AdjustedEbitdaContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_88PaZddhkkCd7Rqlu4UDKA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41603 - Disclosure - Segment Reporting - Reconciliation of Net Loss to Adjusted EBITDA (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails", "shortName": "Segment Reporting - Reconciliation of Net Loss to Adjusted EBITDA (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": "-3", "lang": null, "name": "trhc:BusinessOptimizationExpenses", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10101 - Disclosure - Nature of Business", "role": "http://www.tabularasahealthcare.com/role/DisclosureNatureOfBusiness", "shortName": "Nature of Business", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_88PaZddhkkCd7Rqlu4UDKA", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax", "reportCount": 1, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41604 - Disclosure - Segment Reporting - Reconciliation of Net Loss to Adjusted EBITDA (Loss), Discontinued Operations (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaLossDiscontinuedOperationsDetails", "shortName": "Segment Reporting - Reconciliation of Net Loss to Adjusted EBITDA (Loss), Discontinued Operations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_us-gaap_DisposalGroupClassificationAxis_us-gaap_SegmentDiscontinuedOperationsMember_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_trhc_DosemerxSinfonarxAndPrescribewellnessBusinessesMember_0ChqRmMhdEuvO2ZqTs3RgA", "decimals": "-3", "lang": null, "name": "us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_NKZrGXZuwEyuDZrcvJIJzw", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NotesPayableRelatedPartiesNoncurrent", "reportCount": 1, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41701 - Disclosure - Related Party Transactions (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureRelatedPartyTransactionsDetails", "shortName": "Related Party Transactions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_7_1_2022_To_9_30_2022_us-gaap_RelatedPartyTransactionAxis_trhc_PharmacyServicesAndPaceSolutionsServicesMember_bXtbK4Ofoke5LdRlRNqh5w", "decimals": "-3", "lang": null, "name": "us-gaap:RevenueFromRelatedParties", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_E8Uh9_FOPEqQVzVG8KcSJA", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_9_30_2022_NKZrGXZuwEyuDZrcvJIJzw", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "Unit_Divide_USD_shares_WJ_Ei8T9O0SBOi0SeeRI1A", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41801 - Disclosure - Rights Plan (Details)", "role": "http://www.tabularasahealthcare.com/role/DisclosureRightsPlanDetails", "shortName": "Rights Plan (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "trhc:RightsAgreementTextBlock", "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "As_Of_7_25_2022_us-gaap_StatementClassOfStockAxis_trhc_SeriesJuniorParticipatingPreferredStockMember__BVDm4F0j0-mXL4YZ_Tn6A", "decimals": "INF", "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_WJ_Ei8T9O0SBOi0SeeRI1A", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10201 - Disclosure - Basis of Presentation, Summary of Significant Accounting Policies, and Recent Accounting Pronouncements", "role": "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements", "shortName": "Basis of Presentation, Summary of Significant Accounting Policies, and Recent Accounting Pronouncements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "trhc-20220930x10q.htm", "contextRef": "Duration_1_1_2022_To_9_30_2022_Qlu-NRLwDUGI0cS3E1FJbg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 98, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r608" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r609" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r606" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r606" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r606" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r611" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r606" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r606" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r606" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r606" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r605" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r607" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r128", "r183", "r196", "r197", "r198", "r199", "r201", "r203", "r207", "r274", "r275", "r276", "r277", "r278", "r279", "r281", "r282", "r284", "r286", "r287" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingEbitdaDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r128", "r183", "r196", "r197", "r198", "r199", "r201", "r203", "r207", "r274", "r275", "r276", "r277", "r278", "r279", "r281", "r282", "r284", "r286", "r287" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingEbitdaDetails" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r73", "r75", "r126", "r127", "r294", "r334" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsVendorFinancingArrangementsDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": { "auth_ref": [ "r0", "r133", "r138", "r144", "r221", "r429", "r430", "r431", "r443", "r444", "r480", "r481", "r482", "r483", "r515" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption, Adjustment" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAxis": { "auth_ref": [ "r0", "r133", "r138", "r144", "r221", "r429", "r430", "r431", "r443", "r444", "r480", "r481", "r482", "r483", "r515" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption [Axis]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionDomain": { "auth_ref": [ "r0", "r133", "r138", "r144", "r221", "r429", "r430", "r431", "r443", "r444", "r480", "r481", "r482", "r483", "r515" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption [Domain]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r213", "r359", "r365", "r579" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsConcentrationsDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r267", "r268", "r269", "r270", "r293", "r333", "r382", "r385", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r577", "r580", "r599", "r600" ], "lang": { "en-us": { "role": { "label": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails", "http://www.tabularasahealthcare.com/role/DisclosureRevenueGeneralDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPerformanceBasedEquityAwardsDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationRestrictedCommonStockAndRestrictedStockUnitsDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r267", "r268", "r269", "r270", "r293", "r333", "r382", "r385", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r577", "r580", "r599", "r600" ], "lang": { "en-us": { "role": { "label": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRevenueGeneralDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPerformanceBasedEquityAwardsDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationRestrictedCommonStockAndRestrictedStockUnitsDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r213", "r359", "r365", "r579" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsConcentrationsDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r210", "r268", "r269", "r359", "r363", "r542", "r576", "r578" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRevenueDisaggregationDetails", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingRevenueDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r210", "r268", "r269", "r359", "r363", "r542", "r576", "r578" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRevenueDisaggregationDetails", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingRevenueDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r259", "r267", "r268", "r269", "r270", "r293", "r333", "r371", "r382", "r385", "r417", "r418", "r419", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r577", "r580", "r599", "r600" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails", "http://www.tabularasahealthcare.com/role/DisclosureRevenueGeneralDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPerformanceBasedEquityAwardsDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationRestrictedCommonStockAndRestrictedStockUnitsDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r259", "r267", "r268", "r269", "r270", "r293", "r333", "r371", "r382", "r385", "r417", "r418", "r419", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r577", "r580", "r599", "r600" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails", "http://www.tabularasahealthcare.com/role/DisclosureRevenueGeneralDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPerformanceBasedEquityAwardsDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationRestrictedCommonStockAndRestrictedStockUnitsDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r74", "r75", "r126", "r127", "r294", "r334" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsVendorFinancingArrangementsDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r139", "r144", "r266", "r383" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleSeniorSubordinatedNotesDetails" ], "xbrltype": "domainItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r139", "r144", "r266", "r383", "r530" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleSeniorSubordinatedNotesDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r215", "r522" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationRestrictedCommonStockAndRestrictedStockUnitsDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationRestrictedCommonStockAndRestrictedStockUnitsDetails" ], "xbrltype": "domainItemType" }, "trhc_AccountsReceivableNetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing accounts receivable net.", "label": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "trhc_AccruedExpensesAndOtherLiabilitiesCurrentAndNoncurrentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to the accrued expenses and other liabilities current and noncurrent.", "label": "Accrued expenses and other liabilities, Current and noncurrent" } } }, "localname": "AccruedExpensesAndOtherLiabilitiesCurrentAndNoncurrentMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsVendorFinancingArrangementsDetails" ], "xbrltype": "domainItemType" }, "trhc_AccumulatedAmortizationCloudComputingImplementationCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated amortization of cloud computing implementation costs.", "label": "Accumulated Amortization, Cloud Computing Implementation Costs", "terseLabel": "Accumulated amortization, cloud computing implementation costs" } } }, "localname": "AccumulatedAmortizationCloudComputingImplementationCosts", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsCloudComputingArrangementsDetails" ], "xbrltype": "monetaryItemType" }, "trhc_AcquisitionRelatedContingentConsiderationPaid": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of acquisition-related contingent consideration paid.", "label": "Acquisition-Related Contingent Consideration Paid", "negatedLabel": "Acquisition-related contingent consideration paid" } } }, "localname": "AcquisitionRelatedContingentConsiderationPaid", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "trhc_AdjustedEbitda": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of adjusted earnings before income tax, depreciation and amortization.", "label": "Adjusted EBITDA", "totalLabel": "Total Adjusted EBITDA (loss)" } } }, "localname": "AdjustedEbitda", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails" ], "xbrltype": "monetaryItemType" }, "trhc_AdjustedEbitdaContinuingOperations": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails": { "order": 13.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of adjusted earnings before income tax, depreciation and amortization from continuing operations.", "label": "Adjusted EBITDA, Continuing Operations", "terseLabel": "Adjusted EBITDA (loss) from continuing operations", "verboseLabel": "Adjusted EBITDA from continuing operations" } } }, "localname": "AdjustedEbitdaContinuingOperations", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingEbitdaDetails", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails" ], "xbrltype": "monetaryItemType" }, "trhc_AdjustedEbitdaDiscontinuedOperations": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails": { "order": 2.0, "parentTag": "trhc_AdjustedEbitda", "weight": 1.0 }, "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaLossDiscontinuedOperationsDetails": { "order": 8.0, "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of adjusted earnings before income tax, depreciation and amortization from discontinued operations.", "label": "Adjusted EBITDA, Discontinued Operations", "terseLabel": "Adjusted EBITDA (loss) from discontinued operations" } } }, "localname": "AdjustedEbitdaDiscontinuedOperations", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaLossDiscontinuedOperationsDetails" ], "xbrltype": "monetaryItemType" }, "trhc_AmortizationOfCloudComputingImplementationCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of amortization charged against earnings during the period for cloud computing implementation costs.", "label": "Amortization of Cloud Computing Implementation Costs", "terseLabel": "Amortization expense, cloud computing implementation costs" } } }, "localname": "AmortizationOfCloudComputingImplementationCosts", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsCloudComputingArrangementsDetails" ], "xbrltype": "monetaryItemType" }, "trhc_AmortizationOfVendorFinancingArrangementDiscount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize discount of vendor financing arrangements.", "label": "Amortization of Vendor Financing Arrangement Discount", "terseLabel": "Vendor Financing Arrangements, Non-cash interest expense" } } }, "localname": "AmortizationOfVendorFinancingArrangementDiscount", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsVendorFinancingArrangementsDetails" ], "xbrltype": "monetaryItemType" }, "trhc_AssetImpairmentChargesTotalIncludingDiscontinuedOperations": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. Includes impairment within disposal group and discontinued operation.", "label": "Asset Impairment Charges, Total, Including Discontinued Operations", "terseLabel": "Impairment charges" } } }, "localname": "AssetImpairmentChargesTotalIncludingDiscontinuedOperations", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "trhc_AwardDate27April2021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Award date of 27 April, 2021.", "label": "Award Date, April 27, 2021" } } }, "localname": "AwardDate27April2021Member", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPerformanceBasedEquityAwardsDetails" ], "xbrltype": "domainItemType" }, "trhc_AwardDate29october2020Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Award date of October 29, 2020.", "label": "Award Date, October 29, 2020" } } }, "localname": "AwardDate29october2020Member", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPerformanceBasedEquityAwardsDetails" ], "xbrltype": "domainItemType" }, "trhc_AwardDateAugust222022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Award date of August 22, 2022.", "label": "Award Date, August 22, 2022" } } }, "localname": "AwardDateAugust222022Member", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPerformanceBasedEquityAwardsDetails" ], "xbrltype": "domainItemType" }, "trhc_AwardDateFirstQuarter2021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Award date of first quarter, 2021.", "label": "Award Date, First Quarter, 2021" } } }, "localname": "AwardDateFirstQuarter2021Member", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOtherStockAwardsDetails" ], "xbrltype": "domainItemType" }, "trhc_AwardDateFirstQuarter2022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Award date of first quarter, 2022.", "label": "Award Date, First Quarter, 2022" } } }, "localname": "AwardDateFirstQuarter2022Member", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOtherStockAwardsDetails" ], "xbrltype": "domainItemType" }, "trhc_AwardDateSecondQuarter2022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Award date of second quarter, 2022.", "label": "Award Date, Second Quarter, 2022" } } }, "localname": "AwardDateSecondQuarter2022Member", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOtherStockAwardsDetails" ], "xbrltype": "domainItemType" }, "trhc_AwardDateThirdQuarter2022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Award date of third quarter, 2022.", "label": "Award Date, Third Quarter, 2022" } } }, "localname": "AwardDateThirdQuarter2022Member", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOtherStockAwardsDetails" ], "xbrltype": "domainItemType" }, "trhc_BusinessOptimizationExpenses": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails": { "order": 5.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses associated with business optimization. May include contract termination payments, severance, retention payments, and other employee and non-recurring vendor costs related to business optimization initiatives .", "label": "Business Optimization Expenses", "terseLabel": "Business optimization expenses" } } }, "localname": "BusinessOptimizationExpenses", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails" ], "xbrltype": "monetaryItemType" }, "trhc_BusinessPartnershipAgreementEstimatedFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of estimated fees to be paid under the business partnership agreement.", "label": "Business Partnership Agreement, Estimated Fees", "terseLabel": "Total estimated fees under business partnership agreement" } } }, "localname": "BusinessPartnershipAgreementEstimatedFees", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsVendorFinancingArrangementsDetails" ], "xbrltype": "monetaryItemType" }, "trhc_BusinessPartnershipAgreementNumberOfEmployeesHiredByThirdPartyProvider": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of entity's employees hired by third-party provider.", "label": "Business Partnership Agreement, Number of Employees Hired By Third Party Provider", "terseLabel": "Number of Company employees hired by third-party provider." } } }, "localname": "BusinessPartnershipAgreementNumberOfEmployeesHiredByThirdPartyProvider", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsVendorFinancingArrangementsDetails" ], "xbrltype": "integerItemType" }, "trhc_BusinessPartnershipAgreementTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term of business partnership agreement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Business Partnership Agreement, Term", "terseLabel": "Term of business partnership agreement." } } }, "localname": "BusinessPartnershipAgreementTerm", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsVendorFinancingArrangementsDetails" ], "xbrltype": "durationItemType" }, "trhc_BusinessProcessSupportAndTechnologyServicesPartnerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business process support and technology services partner.", "label": "Business process support and technology services partner" } } }, "localname": "BusinessProcessSupportAndTechnologyServicesPartnerMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsVendorFinancingArrangementsDetails" ], "xbrltype": "domainItemType" }, "trhc_CapitalizedComputerSoftwareNotYetSubjectToAmortization": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of capitalized computer software costs not yet subject to amortization.", "label": "Capitalized Computer Software, Not Yet Subject To Amortization", "terseLabel": "Capitalized software development costs included above not yet subject to amortization" } } }, "localname": "CapitalizedComputerSoftwareNotYetSubjectToAmortization", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSoftwareDevelopmentCostsDetails" ], "xbrltype": "monetaryItemType" }, "trhc_CapitalizedImplementationCostsCloudComputing": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of capitalized implementation cost for cloud computing arrangement net of accumulated amortization as of the balance sheet date.", "label": "Capitalized Implementation Costs, Cloud Computing", "terseLabel": "Capitalized cloud computing implementation costs" } } }, "localname": "CapitalizedImplementationCostsCloudComputing", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsCloudComputingArrangementsDetails" ], "xbrltype": "monetaryItemType" }, "trhc_CapitalizedSoftwareDevelopmentCostsAccumulatedAmortization": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureSoftwareDevelopmentCostsDetails": { "order": 2.0, "parentTag": "trhc_CapitalizedSoftwareDevelopmentCostsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "For each balance sheet presented, the amount of accumulated amortization for internally developed computer software for long-term internal use.", "label": "Capitalized Software Development Costs, Accumulated Amortization", "negatedLabel": "Less: accumulated amortization" } } }, "localname": "CapitalizedSoftwareDevelopmentCostsAccumulatedAmortization", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSoftwareDevelopmentCostsDetails" ], "xbrltype": "monetaryItemType" }, "trhc_CapitalizedSoftwareDevelopmentCostsGross": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureSoftwareDevelopmentCostsDetails": { "order": 1.0, "parentTag": "trhc_CapitalizedSoftwareDevelopmentCostsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of capitalized costs for internally developed computer software for long-term internal use.", "label": "Capitalized Software Development Costs, Gross", "terseLabel": "Software development costs" } } }, "localname": "CapitalizedSoftwareDevelopmentCostsGross", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSoftwareDevelopmentCostsDetails" ], "xbrltype": "monetaryItemType" }, "trhc_CapitalizedSoftwareDevelopmentCostsNet": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureSoftwareDevelopmentCostsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of costs for internally developed computer software for long-term internal use net of accumulated amortization as of the balance sheet date.", "label": "Capitalized Software Development Costs Net", "terseLabel": "Software development costs, net", "totalLabel": "Software development costs, net" } } }, "localname": "CapitalizedSoftwareDevelopmentCostsNet", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSoftwareDevelopmentCostsDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "trhc_CareventionHealthcareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents CareVention HealthCare, an operating segment of the entity.", "label": "CareVention HealthCare" } } }, "localname": "CareventionHealthcareMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRevenueDisaggregationDetails", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingEbitdaDetails", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingRevenueDetails" ], "xbrltype": "domainItemType" }, "trhc_ClientClaimsPayableCurrent": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligations incurred for client claims payable within one year or the normal operating cycle, if longer.", "label": "Client Claims Payable, Current", "terseLabel": "Client claims payable" } } }, "localname": "ClientClaimsPayableCurrent", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "trhc_ClientClaimsReceivableCurrent": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of client claims receivable, representing amounts invoiced for adjudicated client claims, due within one year or the normal operating cycle, if longer.", "label": "Client Claims Receivable, Current", "terseLabel": "Client claims receivable" } } }, "localname": "ClientClaimsReceivableCurrent", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "trhc_ClientClaimsReceivableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Client claims receivable, representing amounts invoiced for adjudicated client claims.", "label": "Client Claims Receivable" } } }, "localname": "ClientClaimsReceivableMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsConcentrationsDetails" ], "xbrltype": "domainItemType" }, "trhc_ClientFundsObligations": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureAccruedExpensesAndOtherLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value of the balance sheet date for client funds obligations.", "label": "Client Funds Obligations", "terseLabel": "Client funds obligations" } } }, "localname": "ClientFundsObligations", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureAccruedExpensesAndOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "trhc_CloudComputingArrangementsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cloud computing arrangements.", "label": "Cloud Computing Arrangements [Policy Text Block]", "terseLabel": "Cloud Computing Arrangements" } } }, "localname": "CloudComputingArrangementsPolicyTextBlock", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies" ], "xbrltype": "textBlockItemType" }, "trhc_CloudHostingAndSupportServicesProviderOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents provider of cloud hosting and support services, one.", "label": "Cloud hosting and support services provider under October 2021 agreement" } } }, "localname": "CloudHostingAndSupportServicesProviderOneMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureCommitmentsAndContingenciesVendorPurchaseAgreementsDetails" ], "xbrltype": "domainItemType" }, "trhc_CloudHostingAndSupportServicesProviderOneUnderJune2021AgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents provider of cloud hosting and support services, one, under June 2021 agreement.", "label": "Cloud hosting and support services provider under June 2021 agreement" } } }, "localname": "CloudHostingAndSupportServicesProviderOneUnderJune2021AgreementMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureCommitmentsAndContingenciesVendorPurchaseAgreementsDetails" ], "xbrltype": "domainItemType" }, "trhc_CloudHostingServicesOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents cloud hosting services.", "label": "Cloud hosting services provider" } } }, "localname": "CloudHostingServicesOneMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureCommitmentsAndContingenciesVendorPurchaseAgreementsDetails" ], "xbrltype": "domainItemType" }, "trhc_CommonStockDividendsPreferredSharePurchaseRightDeclaredRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ratio of dividends of preferred share purchase rights declared during the period to each share of common stock outstanding.", "label": "Common Stock Dividends, Preferred Share Purchase Right, Declared, Ratio", "terseLabel": "Dividend declared in preferred share purchase rights per common share outstanding" } } }, "localname": "CommonStockDividendsPreferredSharePurchaseRightDeclaredRatio", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRightsPlanDetails" ], "xbrltype": "pureItemType" }, "trhc_ConcentrationRiskNumberOfCustomers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents number of customers that equal or exceed the concentration threshold.", "label": "Concentration Risk, Number of Customers", "terseLabel": "Number of clients" } } }, "localname": "ConcentrationRiskNumberOfCustomers", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsConcentrationsDetails" ], "xbrltype": "integerItemType" }, "trhc_ConsiderationPayableToCustomersCurrent": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureAccruedExpensesAndOtherLiabilitiesDetails": { "order": 10.0, "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The current portion, due within one year or one operating cycle, if longer, of consideration payable to customers.", "label": "Consideration Payable to Customers Current", "terseLabel": "Consideration payable to customer" } } }, "localname": "ConsiderationPayableToCustomersCurrent", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureAccruedExpensesAndOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "trhc_ConsultantServicesAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to Consultant Services agreements between the entity and related parties.", "label": "Consultant Services Agreements" } } }, "localname": "ConsultantServicesAgreementsMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "trhc_ContractLaborCurrent": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureAccruedExpensesAndOtherLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for contract labor. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Contract Labor, Current", "terseLabel": "Contract labor" } } }, "localname": "ContractLaborCurrent", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureAccruedExpensesAndOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "trhc_ContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Contract with Customer [Abstract]", "terseLabel": "Contract with customer" } } }, "localname": "ContractWithCustomerAbstract", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRevenueGeneralDetails" ], "xbrltype": "stringItemType" }, "trhc_ContractWithCustomerAssetAndLiabilityAndReceivablesBalancesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of contract and receivables balances.", "label": "Contract with Customer, Asset and Liability, and Receivables Balances [Table Text Block]", "terseLabel": "Schedule of contract assets and contract liabilities from contracts with customers" } } }, "localname": "ContractWithCustomerAssetAndLiabilityAndReceivablesBalancesTableTextBlock", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRevenueTables" ], "xbrltype": "textBlockItemType" }, "trhc_ContractWithCustomerAssetAndLiabilityChangesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of changes in contract balances.", "label": "Contract with Customer, Asset and Liability, Changes [Table Text Block]", "terseLabel": "Schedule of significant changes in the contract assets and the contract liabilities balances" } } }, "localname": "ContractWithCustomerAssetAndLiabilityChangesTableTextBlock", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRevenueTables" ], "xbrltype": "textBlockItemType" }, "trhc_ContractWithCustomerAssetCashReceived": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time from transfer to receivable due to cash received.", "label": "Contract with Customer, Asset, Cash Received", "negatedLabel": "Decreases due to cash received" } } }, "localname": "ContractWithCustomerAssetCashReceived", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRevenueChangeInContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "trhc_ContractWithCustomerAssetChangeExcludingReclassificationToReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time excluding amounts transferred to receivables during the period.", "label": "Contract with Customer, Asset, Change Excluding Reclassification To Receivable", "terseLabel": "Changes during the year, net of reclassifications to receivables" } } }, "localname": "ContractWithCustomerAssetChangeExcludingReclassificationToReceivable", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRevenueChangeInContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "trhc_ContractWithCustomerAssetChangeInEstimate": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time due to change in estimate.", "label": "Contract with Customer, Asset, Change in Estimate", "terseLabel": "Changes to the contract assets at the beginning of the period as a result of changes in estimates" } } }, "localname": "ContractWithCustomerAssetChangeInEstimate", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRevenueChangeInContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "trhc_ContractWithCustomerLiabilityCustomerDepositsCurrent": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureAccruedExpensesAndOtherLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of customer deposits, classified as current.", "label": "Contract with Customer, Liability, Customer Deposits, Current", "terseLabel": "Customer deposits" } } }, "localname": "ContractWithCustomerLiabilityCustomerDepositsCurrent", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureAccruedExpensesAndOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "trhc_ContractWithCustomerLiabilityExcludingCustomerDepositsCurrent": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureAccruedExpensesAndOtherLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable excluding customer deposits, classified as current.", "label": "Contract with Customer, Liability, Excluding Customer Deposits, Current", "terseLabel": "Contract liability" } } }, "localname": "ContractWithCustomerLiabilityExcludingCustomerDepositsCurrent", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureAccruedExpensesAndOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "trhc_ContractWithCustomerLiabilityIncreaseDueToCashReceived": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in obligation to transfer good or service to customer due to cash received, excluding amounts recognized as revenue during the period.", "label": "Contract with Customer Liability, Increase Due to Cash Received", "terseLabel": "Increases due to cash received, excluding amounts recognized as revenue during the period" } } }, "localname": "ContractWithCustomerLiabilityIncreaseDueToCashReceived", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRevenueChangeInContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "trhc_ContractWithCustomerTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term of contract with customer, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Contract with Customer, Term", "terseLabel": "Client contract term" } } }, "localname": "ContractWithCustomerTerm", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRevenueGeneralDetails" ], "xbrltype": "durationItemType" }, "trhc_ContractWithCustomerTerminationNoticePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Termination notice period of contract with customer, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Contract with Customer, Termination Notice Period", "terseLabel": "Termination notice period" } } }, "localname": "ContractWithCustomerTerminationNoticePeriod", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRevenueGeneralDetails" ], "xbrltype": "durationItemType" }, "trhc_ConvertibleNoteWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of common stock in accordance with the terms of the instrument, usually upon payment of a specified amount. Issued in connection with convertible note offering.", "label": "Common stock warrants/Convertible note warrants" } } }, "localname": "ConvertibleNoteWarrantMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleNoteHedgeAndWarrantTransactionsDetails", "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareAntiDilutiveSecuritiesDetails" ], "xbrltype": "domainItemType" }, "trhc_ConvertibleSeniorSubordinatedNotesExcludingRelatedPartyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to convertible senior subordinated notes, excluding related party.", "label": "Convertible senior subordinated notes - excluding related party" } } }, "localname": "ConvertibleSeniorSubordinatedNotesExcludingRelatedPartyMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "trhc_ConvertibleSeniorSubordinatedNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to convertible senior subordinated notes.", "label": "2026 Notes, Convertible Senior Subordinated Notes" } } }, "localname": "ConvertibleSeniorSubordinatedNotesMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureFairValueMeasurementsFinancialInstrumentsDetails", "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleSeniorSubordinatedNotesDetails", "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "trhc_ConvertibleSeniorSubordinatedNotesRelatedPartyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to convertible senior subordinated notes - related party.", "label": "Convertible senior subordinated notes - related party" } } }, "localname": "ConvertibleSeniorSubordinatedNotesRelatedPartyMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "trhc_CooperationAgreementExpense": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails": { "order": 8.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cooperation agreement costs during the period.", "label": "Cooperation Agreement Expense", "terseLabel": "Cooperation agreement costs" } } }, "localname": "CooperationAgreementExpense", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails" ], "xbrltype": "monetaryItemType" }, "trhc_CooperationAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to the Cooperation agreement between the entity and a related party.", "label": "Cooperation Agreement" } } }, "localname": "CooperationAgreementMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "trhc_CostOfProductRevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of product revenue.", "label": "Cost of revenue - product" } } }, "localname": "CostOfProductRevenueMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "trhc_CostOfServiceRevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of service revenue.", "label": "Cost of revenue - service" } } }, "localname": "CostOfServiceRevenueMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "trhc_CustomerBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to a second customer.", "label": "Client Two" } } }, "localname": "CustomerBMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsConcentrationsDetails" ], "xbrltype": "domainItemType" }, "trhc_CustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to one customer.", "label": "Client One" } } }, "localname": "CustomerMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsConcentrationsDetails" ], "xbrltype": "domainItemType" }, "trhc_DataAggregationPartnerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents data aggregation partner.", "label": "Data aggregation partner" } } }, "localname": "DataAggregationPartnerMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureCommitmentsAndContingenciesVendorPurchaseAgreementsDetails" ], "xbrltype": "domainItemType" }, "trhc_DebtConversionScenarioOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt conversion scenario one.", "label": "Debt Conversion Scenario One" } } }, "localname": "DebtConversionScenarioOneMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleSeniorSubordinatedNotesDetails" ], "xbrltype": "domainItemType" }, "trhc_DebtConversionScenarioTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt conversion scenario two.", "label": "Debt Conversion Scenario Two" } } }, "localname": "DebtConversionScenarioTwoMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleSeniorSubordinatedNotesDetails" ], "xbrltype": "domainItemType" }, "trhc_DebtInstrumentConvertiblePrincipalAmountUsedInCalculationForConversionEligibility": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Principal amount of convertible debt used in calculation to determine eligibility of conversion.", "label": "Debt Instrument, Convertible, Principal Amount, Used in Calculation for Conversion Eligibility", "terseLabel": "Principal amount" } } }, "localname": "DebtInstrumentConvertiblePrincipalAmountUsedInCalculationForConversionEligibility", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleSeniorSubordinatedNotesDetails" ], "xbrltype": "monetaryItemType" }, "trhc_DebtInstrumentPremiumPaidForNoteHedges": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount of premiums paid for the note hedges.", "label": "Debt Instrument, Premium Paid For Note Hedges", "terseLabel": "Premiums paid for the note hedges" } } }, "localname": "DebtInstrumentPremiumPaidForNoteHedges", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleNoteHedgeAndWarrantTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "trhc_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNetExcludingRelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of unamortized debt discount (premium) and debt\n issuance costs excluding related party debt.", "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net, Excluding Related Party", "terseLabel": "Long-term debt, discount" } } }, "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNetExcludingRelatedParty", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "trhc_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNetRelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of unamortized debt discount (premium) and debt\n issuance costs for related party debt.", "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net, Related Party", "terseLabel": "Long-term debt - related party, discount" } } }, "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNetRelatedParty", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "trhc_DeferredTaxAssetIncreaseDecreaseAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the deferred tax asset.", "label": "Deferred Tax Asset, Increase (Decrease), Amount", "terseLabel": "Increase in deferred tax asset" } } }, "localname": "DeferredTaxAssetIncreaseDecreaseAmount", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "trhc_DepreciationAmortizationAndAccretionNetTotalIncludingDiscontinuedOperations": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method including discontinued operations.", "label": "Depreciation, Amortization and Accretion, Net, Total, Including Discontinued Operations", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAmortizationAndAccretionNetTotalIncludingDiscontinuedOperations", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "trhc_DiscontinuedOperationDivestitureRelatedCosts": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails": { "order": 9.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents divestiture-related costs incurred which have been expensed during the period.", "label": "Discontinued Operation, Divestiture Related Costs", "terseLabel": "Divestiture-related expense" } } }, "localname": "DiscontinuedOperationDivestitureRelatedCosts", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails" ], "xbrltype": "monetaryItemType" }, "trhc_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTaxMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing discontinued operations income (loss).", "label": "Discontinued operations" } } }, "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTaxMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "trhc_DiscontinuedOperationsAggregateGainLossOnDisposalIncludingImpairment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of aggregate gain/loss on disposal of discontinued operations including impairment during the period.", "label": "Discontinued Operations, Aggregate Gain Loss On Disposal Including Impairment", "terseLabel": "Aggregate gain/(loss) including impairment" } } }, "localname": "DiscontinuedOperationsAggregateGainLossOnDisposalIncludingImpairment", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails" ], "xbrltype": "monetaryItemType" }, "trhc_DiscontinuedOperationsSaleCompletionPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period within which sale is highly probable to be completed, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Discontinued Operations, Sale Completion Period", "terseLabel": "Period within which sale is highly probable" } } }, "localname": "DiscontinuedOperationsSaleCompletionPeriod", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleDetails" ], "xbrltype": "durationItemType" }, "trhc_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesAndOtherLiabilitiesCurrentTotal": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as accrued liabilities and other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Accrued Liabilities and Other Liabilities, Current, Total", "terseLabel": "Accrued expenses and other liabilities" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesAndOtherLiabilitiesCurrentTotal", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "trhc_DisposalGroupIncludingDiscontinuedOperationAccumulatedImpairment": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of accumulated impairment of carrying value of assets attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Accumulated Impairment", "negatedLabel": "Impairment of carrying value" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAccumulatedImpairment", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "trhc_DisposalGroupIncludingDiscontinuedOperationCashAdjustmentsNetWorkingCapital": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash received for certain adjustments related to the net working capital subsequent to date of sale for disposal of assets and liabilities, including discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Cash Adjustments, Net Working Capital", "terseLabel": "Amount of cash received for certain adjustments related to net working capital subsequent to date of sale", "verboseLabel": "Additional consideration subsequently paid due to customary post-closing adjustments." } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationCashAdjustmentsNetWorkingCapital", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlowsParenthetical" ], "xbrltype": "monetaryItemType" }, "trhc_DisposalGroupIncludingDiscontinuedOperationConsiderationPayableAtClosing": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash consideration received or receivable at closing for the disposal of assets and liabilities, including discontinued operation. Excludes potential contingent consideration to be received.", "label": "Disposal Group, Including Discontinued Operation, Consideration Payable At Closing", "verboseLabel": "Cash consideration received" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationPayableAtClosing", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleDetails" ], "xbrltype": "monetaryItemType" }, "trhc_DisposalGroupIncludingDiscontinuedOperationImpairmentCharges": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessResultsOfOperationsDetails": { "order": 4.0, "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTaxAttributableToParent", "weight": -1.0 }, "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaLossDiscontinuedOperationsDetails": { "order": 3.0, "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of impairment charges attributable to disposal group, including, but not limited to, discontinued operation, classified as a discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Impairment Charges", "terseLabel": "Impairment charges", "verboseLabel": "Impairment charges" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationImpairmentCharges", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessOperatingNonCashItemsAndInvestingActivitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessResultsOfOperationsDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleOperatingNonCashItemsAndInvestingActivitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleResultsOfOperationsDetails", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaLossDiscontinuedOperationsDetails" ], "xbrltype": "monetaryItemType" }, "trhc_DisposalGroupIncludingDiscontinuedOperationImpairmentChargesGoodwill": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of goodwill impairment charges attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Impairment Charges, Goodwill", "terseLabel": "Goodwill impairment" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationImpairmentChargesGoodwill", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleDetails" ], "xbrltype": "monetaryItemType" }, "trhc_DisposalGroupIncludingDiscontinuedOperationImpairmentChargesNetAssetsHeldForSale": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of impairment charges from net assets held for sale attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Impairment Charges, Net Assets Held For Sale", "terseLabel": "Impairment charge on net assets held for sale" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationImpairmentChargesNetAssetsHeldForSale", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleDetails" ], "xbrltype": "monetaryItemType" }, "trhc_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as operating lease liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Operating Lease Liabilities, Current", "terseLabel": "Operating lease liabilities" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesCurrent", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "trhc_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesNoncurrent": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as operating lease liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Operating Lease Liabilities, Noncurrent", "terseLabel": "Noncurrent operating lease liabilities" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilitiesNoncurrent", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "trhc_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as operating lease right-of-use assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Operating Lease Right-of-Use Assets, Current", "terseLabel": "Operating lease right-of-use assets" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsCurrent", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "trhc_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsNoncurrent": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as operating lease right-of-use assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer..", "label": "Disposal Group, Including Discontinued Operation, Operating Lease Right-of-Use Assets, Noncurrent", "terseLabel": "Operating lease right-of-use assets" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetsNoncurrent", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "trhc_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCostsNetCurrent": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails": { "order": 8.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as software development costs, net attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Software Development Costs, Net, Current", "terseLabel": "Software development costs, net" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCostsNetCurrent", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "trhc_DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCostsNetNoncurrent": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as software development costs, net attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Software Development Costs, Net, Noncurrent", "terseLabel": "Software development costs, net" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationSoftwareDevelopmentCostsNetNoncurrent", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "trhc_DivestitureClosingFeesPayableCurrent": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureAccruedExpensesAndOtherLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability for divestiture closing fees payable that is expected to be satisfied within the next 12 months, as of balance sheet date.", "label": "Divestiture Closing Fees Payable, Current", "terseLabel": "Divestiture closing fees" } } }, "localname": "DivestitureClosingFeesPayableCurrent", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureAccruedExpensesAndOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "trhc_DivestitureRelatedExpenseDiscontinuedOperations": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaLossDiscontinuedOperationsDetails": { "order": 6.0, "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of divestiture-related expense of discontinued operations.", "label": "Divestiture-Related Expense, Discontinued Operations", "terseLabel": "Divestiture-related expense" } } }, "localname": "DivestitureRelatedExpenseDiscontinuedOperations", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaLossDiscontinuedOperationsDetails" ], "xbrltype": "monetaryItemType" }, "trhc_DomainNameMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to domain name.", "label": "Domain name" } } }, "localname": "DomainNameMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "trhc_DosemeAndSinfonarxBusinessesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information relating to DoseMe and SinfonaRx businesses.", "label": "DoseMe and SinfonaRx businesses" } } }, "localname": "DosemeAndSinfonarxBusinessesMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleOperatingNonCashItemsAndInvestingActivitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleResultsOfOperationsDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsTables" ], "xbrltype": "domainItemType" }, "trhc_DosemerxSinfonarxAndPrescribewellnessBusinessesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DoseMeRx, SinfonaRx and PrescribeWellness businesses.", "label": "DoseMe, SinfonaRx and PrescribeWellness businesses" } } }, "localname": "DosemerxSinfonarxAndPrescribewellnessBusinessesMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaLossDiscontinuedOperationsDetails" ], "xbrltype": "domainItemType" }, "trhc_EarningsPerShareDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Earnings Per Share Disclosure [Abstract]", "terseLabel": "Net loss per share:" } } }, "localname": "EarningsPerShareDisclosureAbstract", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "trhc_EmployeeTaxesForSharesWithheldButNotYetPaid": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Future cash outflow to pay employee taxes for shares withheld included in accrued expenses.", "label": "Employee Taxes For Shares Withheld but Not Yet Paid", "terseLabel": "Employee taxes for shares withheld included in accrued expenses" } } }, "localname": "EmployeeTaxesForSharesWithheldButNotYetPaid", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "trhc_EnterpriseSupportAndInformationTechnologyServicesProviderMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents provider of enterprise support and information technology services.", "label": "Enterprise support and information technology services provider" } } }, "localname": "EnterpriseSupportAndInformationTechnologyServicesProviderMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureCommitmentsAndContingenciesVendorPurchaseAgreementsDetails" ], "xbrltype": "domainItemType" }, "trhc_EquityCompensationPlan2016Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to 2016 Equity Compensation Plan.", "label": "2016 Plan" } } }, "localname": "EquityCompensationPlan2016Member", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPlansDetails" ], "xbrltype": "domainItemType" }, "trhc_ExecutiveTransition": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails": { "order": 7.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of executive transition expenses incurred during the period.", "label": "Executive Transition", "terseLabel": "Executive transition" } } }, "localname": "ExecutiveTransition", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails" ], "xbrltype": "monetaryItemType" }, "trhc_IncreaseDecreaseInAccruedLiabilitiesAndOtherLiabilities": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations incurred but not yet paid nor invoiced, and liabilities classified as other.", "label": "Increase (Decrease) in Accrued Liabilities and Other Liabilities", "terseLabel": "Accrued expenses and other liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherLiabilities", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "trhc_IncreaseDecreaseInClientClaimsPayables": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) during the reporting period in due to clients.", "label": "Increase Decrease In Client Claims Payables", "terseLabel": "Client claims payables" } } }, "localname": "IncreaseDecreaseInClientClaimsPayables", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "trhc_IncreaseDecreaseInClientClaimsReceivables": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) during the reporting period in receivables from clients.", "label": "Increase Decrease In Client Claims Receivables", "negatedLabel": "Client claims receivables" } } }, "localname": "IncreaseDecreaseInClientClaimsReceivables", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "trhc_InterestPayableAdditionalCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of additional interest payable as a result of the failure to remove the restrictive legend on debt instrument.", "label": "Interest Payable, Additional, Current", "terseLabel": "Amount of additional interest payable" } } }, "localname": "InterestPayableAdditionalCurrent", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleSeniorSubordinatedNotesDetails" ], "xbrltype": "monetaryItemType" }, "trhc_KarmadataInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "karmadata, Inc., a Delaware corporation (\"KD\").", "label": "KD" } } }, "localname": "KarmadataInc.Member", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails" ], "xbrltype": "domainItemType" }, "trhc_KdAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to karmadata, Inc (KD) assets.", "label": "KD assets" } } }, "localname": "KdAssetsMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails" ], "xbrltype": "domainItemType" }, "trhc_LineOfCreditFacilityAnnualCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used, payable on each anniversary following closing date.", "label": "Line of Credit Facility, Annual, Commitment Fee Percentage", "terseLabel": "Commitment fee payable on each anniversary (as a percent)" } } }, "localname": "LineOfCreditFacilityAnnualCommitmentFeePercentage", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLineOfCreditDetails" ], "xbrltype": "percentItemType" }, "trhc_LineOfCreditFacilityBorrowingSublimit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sublimit provided under the credit facility for cash management services and letter of credit and foreign exchange transactions.", "label": "Line of Credit Facility, Borrowing Sublimit", "terseLabel": "Sublimit of loan" } } }, "localname": "LineOfCreditFacilityBorrowingSublimit", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLineOfCreditDetails" ], "xbrltype": "monetaryItemType" }, "trhc_LoanAndSecurityAgreement2020Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loan and Security Agreement (\"Credit Facility\") entered into on December 18, 2020.", "label": "2020 Credit Facility" } } }, "localname": "LoanAndSecurityAgreement2020Member", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLineOfCreditDetails" ], "xbrltype": "domainItemType" }, "trhc_LongTermDebtExcludingRelatedPartyDebtNoncurrent": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation, related party, and line of credit.", "label": "Long-Term Debt, Excluding Related Party Debt, Noncurrent", "terseLabel": "Long-term debt, net of discount of $3,404 and $5,701, respectively" } } }, "localname": "LongTermDebtExcludingRelatedPartyDebtNoncurrent", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "trhc_MedicationSafetyServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Medication safety services.", "label": "Service - Medication safety services" } } }, "localname": "MedicationSafetyServicesMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRevenueDisaggregationDetails", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingRevenueDetails" ], "xbrltype": "domainItemType" }, "trhc_MedwiseHealthcareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents MedWise HealthCare, an operating segment of the entity.", "label": "MedWise HealthCare" } } }, "localname": "MedwiseHealthcareMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRevenueDisaggregationDetails" ], "xbrltype": "domainItemType" }, "trhc_NamedExecutiveOfficerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Named executive officer.", "label": "Named executive officers" } } }, "localname": "NamedExecutiveOfficerMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationRestrictedCommonStockAndRestrictedStockUnitsDetails" ], "xbrltype": "domainItemType" }, "trhc_NumberOfRelatedPartiesParticipatingInAgreement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of related parties, such as former executive officers, that are participating in the agreement, such as a separation or consulting services agreement.", "label": "Number Of Related Parties Participating In The Agreement", "terseLabel": "Number of former executive officers under the agreement" } } }, "localname": "NumberOfRelatedPartiesParticipatingInAgreement", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "integerItemType" }, "trhc_NumberOfRetiredEmployeesSeparationAgreements": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of retired employees with accelerated vesting related to separation agreements.", "label": "Number of Retired Employees, Separation Agreements", "terseLabel": "Number of retired employees with accelerated vesting related to separation agreements" } } }, "localname": "NumberOfRetiredEmployeesSeparationAgreements", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationRestrictedCommonStockAndRestrictedStockUnitsDetails" ], "xbrltype": "integerItemType" }, "trhc_OtherAssetsCurrentDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Other Current Assets" } } }, "localname": "OtherAssetsCurrentDisclosureAbstract", "nsuri": "http://www.tabularasahealthcare.com/20220930", "xbrltype": "stringItemType" }, "trhc_OtherAssetsDivestitureRelatedConsiderationReceivablesCurrent": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureOtherCurrentAssetsDetails": { "order": 3.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Divestiture related consideration receivables, current.", "label": "Other Assets, Divestiture Related Consideration Receivables, Current", "terseLabel": "Divestiture related consideration receivables" } } }, "localname": "OtherAssetsDivestitureRelatedConsiderationReceivablesCurrent", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "trhc_OtherAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Other Assets [Line Items}", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsLineItems", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsCloudComputingArrangementsDetails" ], "xbrltype": "stringItemType" }, "trhc_OtherAssetsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting other assets.", "label": "Other Assets [Table]" } } }, "localname": "OtherAssetsTable", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsCloudComputingArrangementsDetails" ], "xbrltype": "stringItemType" }, "trhc_OtherMiscellaneousAssetsCurrent": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureOtherCurrentAssetsDetails": { "order": 4.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other miscellaneous current assets classified as other.", "label": "Other Miscellaneous Assets, Current", "terseLabel": "Other" } } }, "localname": "OtherMiscellaneousAssetsCurrent", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "trhc_PaceProductMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Programs of All-Inclusive Care for the Elderly (PACE) Product Revenue.", "label": "PACE product revenue" } } }, "localname": "PaceProductMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRevenueDisaggregationDetails" ], "xbrltype": "domainItemType" }, "trhc_PaceSolutionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Programs of All-Inclusive Care for the Elderly (PACE) Solutions.", "label": "Service - PACE solutions" } } }, "localname": "PaceSolutionsMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRevenueDisaggregationDetails", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingRevenueDetails" ], "xbrltype": "domainItemType" }, "trhc_PaymentsToDevelopSoftwareDiscontinuedOperations": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the development or modification of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization attributable to discontinued operations.", "label": "Payments To Develop Software, Discontinued Operations", "negatedLabel": "Software development costs" } } }, "localname": "PaymentsToDevelopSoftwareDiscontinuedOperations", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessOperatingNonCashItemsAndInvestingActivitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleOperatingNonCashItemsAndInvestingActivitiesDetails" ], "xbrltype": "monetaryItemType" }, "trhc_PharmacyServicesAndPaceSolutionsServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to pharmacy services and certain PACE solutions services to related party.", "label": "Pharmacy services and PACE solutions services" } } }, "localname": "PharmacyServicesAndPaceSolutionsServicesMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "trhc_PreferredSharePurchaseRightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to preferred share purchase rights.", "label": "Preferred Share Purchase Right" } } }, "localname": "PreferredSharePurchaseRightMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRightsPlanDetails" ], "xbrltype": "domainItemType" }, "trhc_PrepaidExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing prepaid expenses.", "label": "Prepaid Expenses [Member]", "verboseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpensesMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsCloudComputingArrangementsDetails" ], "xbrltype": "domainItemType" }, "trhc_PrescribewellnessBusinessAndKdAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to PrescribeWellness business and KD assets.", "label": "PrescribeWellness business and KD assets" } } }, "localname": "PrescribewellnessBusinessAndKdAssetsMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlowsParenthetical" ], "xbrltype": "domainItemType" }, "trhc_PrescribewellnessBusinessMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to PrescribeWellness business.", "label": "PrescribeWellness business" } } }, "localname": "PrescribewellnessBusinessMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessOperatingNonCashItemsAndInvestingActivitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessResultsOfOperationsDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsTables", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlowsParenthetical" ], "xbrltype": "domainItemType" }, "trhc_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetExcludingComputerSoftwareDevelopmentCostAccumulatedDepreciationAndAmortization": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosurePropertyAndEquipmentDetails": { "order": 1.0, "parentTag": "trhc_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetExcludingComputerSoftwareDevelopmentCostAfterAccumulatedDepreciationAndAmortization", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease. Excludes internally developed software for long-term internal use.", "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Excluding Computer Software Development Cost, Accumulated Depreciation and Amortization", "verboseLabel": "Accumulated depreciation" } } }, "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetExcludingComputerSoftwareDevelopmentCostAccumulatedDepreciationAndAmortization", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosurePropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "trhc_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetExcludingComputerSoftwareDevelopmentCostAfterAccumulatedDepreciationAndAmortization": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosurePropertyAndEquipmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset. Excludes internally developed software for long-term internal use.", "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Excluding Computer Software Development Cost, After Accumulated Depreciation and Amortization", "terseLabel": "Property and equipment, net", "totalLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetExcludingComputerSoftwareDevelopmentCostAfterAccumulatedDepreciationAndAmortization", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosurePropertyAndEquipmentDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "trhc_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetExcludingComputerSoftwareDevelopmentCostMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Property, plant, and equipment and finance lease right-of-use asset. Excludes internally developed software for long-term internal use.", "label": "Property and equipment" } } }, "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetExcludingComputerSoftwareDevelopmentCostMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosurePropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "trhc_PurchaseObligationMinimumAmountMonthly": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Minimum monthly amount of goods or services that must be purchased from a supplier in connection with a purchase obligation agreement.", "label": "Purchase Obligation, Minimum Amount, Monthly", "terseLabel": "Monthly minimum purchase obligation" } } }, "localname": "PurchaseObligationMinimumAmountMonthly", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureCommitmentsAndContingenciesVendorPurchaseAgreementsDetails" ], "xbrltype": "monetaryItemType" }, "trhc_PurchaseObligationMinimumAmountPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum amount of product that must be purchased from a supplier in connection with a purchase agreement, as a percent of entity's total product requirement.", "label": "Purchase Obligation, Minimum Amount, Percent", "terseLabel": "Purchase obligation (as a percent)" } } }, "localname": "PurchaseObligationMinimumAmountPercent", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureCommitmentsAndContingenciesVendorPurchaseAgreementsDetails" ], "xbrltype": "percentItemType" }, "trhc_PurchaseObligationRemainingCommitment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Remaining commitment amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.", "label": "Purchase Obligation, Remaining Commitment", "terseLabel": "Remaining commitment" } } }, "localname": "PurchaseObligationRemainingCommitment", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureCommitmentsAndContingenciesVendorPurchaseAgreementsDetails" ], "xbrltype": "monetaryItemType" }, "trhc_ReconciliationOfNetIncomeLossToAdjustedEbitdaContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Reconciliation of Net Income (Loss) to Adjusted EBITDA, Continuing Operations [Abstract]", "terseLabel": "Reconciliation of Net Loss to Adjusted EBITDA from Continuing Operations" } } }, "localname": "ReconciliationOfNetIncomeLossToAdjustedEbitdaContinuingOperationsAbstract", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails" ], "xbrltype": "stringItemType" }, "trhc_ReconciliationOfNetIncomeLossToAdjustedEbitdaDiscontinuedOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Reconciliation of Net Income (Loss) to Adjusted EBITDA, Discontinued Operations [Abstract]", "terseLabel": "Reconciliation of Net Loss from Discontinued Operations, net of tax to Adjusted EBITDA from Discontinued Operations" } } }, "localname": "ReconciliationOfNetIncomeLossToAdjustedEbitdaDiscontinuedOperationsAbstract", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaLossDiscontinuedOperationsDetails" ], "xbrltype": "stringItemType" }, "trhc_RepaymentOfNotesPayableRelatedToAcquisition": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for payment of note payable related to acquisition categorized as financing activity.", "label": "Repayment of Notes Payable Related To Acquisition", "negatedLabel": "Payment of acquisition-related notes payable" } } }, "localname": "RepaymentOfNotesPayableRelatedToAcquisition", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "trhc_ResearchDevelopmentAndComputerSoftwareTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government.", "label": "Research, Development, and Computer Software [Table Text Block]", "terseLabel": "Schedule of capitalized software costs" } } }, "localname": "ResearchDevelopmentAndComputerSoftwareTableTextBlock", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSoftwareDevelopmentCostsTables" ], "xbrltype": "textBlockItemType" }, "trhc_RestrictedStockAndRestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted stock, excluding performance based restricted stock, and restricted stock units.", "label": "Restricted stock and restricted stock units" } } }, "localname": "RestrictedStockAndRestrictedStockUnitsMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareAntiDilutiveSecuritiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationRestrictedCommonStockAndRestrictedStockUnitsDetails" ], "xbrltype": "domainItemType" }, "trhc_RestrictedStockPerformanceBasedRestrictedStockAndRestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted stock, inclusive of performance based restricted stock, and restricted stock units.", "label": "Restricted stock, performance based restricted stock and restricted stock units" } } }, "localname": "RestrictedStockPerformanceBasedRestrictedStockAndRestrictedStockUnitsMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationRestrictedCommonStockAndRestrictedStockUnitsDetails" ], "xbrltype": "domainItemType" }, "trhc_RightsAgreementTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the rights agreement.", "label": "Rights Agreement [Text Block]", "terseLabel": "Rights Plan" } } }, "localname": "RightsAgreementTextBlock", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRightsPlan" ], "xbrltype": "textBlockItemType" }, "trhc_ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities and other current liabilities.", "label": "Schedule of Accrued Liabilities and Other Current Liabilities [Table Text Block]", "terseLabel": "Schedule of accrued expenses and other liabilities" } } }, "localname": "ScheduleOfAccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureAccruedExpensesAndOtherLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "trhc_SeparationAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to Separation agreements between the entity and related parties.", "label": "Separation Agreements" } } }, "localname": "SeparationAgreementsMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "trhc_SeriesJuniorParticipatingPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information pertaining to Series A Junior Participating preferred stock.", "label": "Series A Junior Participating Preferred Stock" } } }, "localname": "SeriesJuniorParticipatingPreferredStockMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRightsPlanDetails" ], "xbrltype": "domainItemType" }, "trhc_SettlementDiscontinuedOperations": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaLossDiscontinuedOperationsDetails": { "order": 5.0, "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of settlement expense attributable to discontinued operations.", "label": "Settlement, Discontinued Operations", "terseLabel": "Settlement" } } }, "localname": "SettlementDiscontinuedOperations", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaLossDiscontinuedOperationsDetails" ], "xbrltype": "monetaryItemType" }, "trhc_ShareBasedCompensationAdditionalDisclosures": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Share-based Compensation, Additional Disclosures", "terseLabel": "Additional disclosures" } } }, "localname": "ShareBasedCompensationAdditionalDisclosures", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsActivityDetails" ], "xbrltype": "stringItemType" }, "trhc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNotYetIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that are vested, but stock (units) have not yet been issued.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested, Not Yet Issued", "terseLabel": "Awards vested but not yet issued" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedNotYetIssued", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationRestrictedCommonStockAndRestrictedStockUnitsDetails" ], "xbrltype": "sharesItemType" }, "trhc_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfShareAchievable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum number of shares achievable under the share based compensation arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Share Achievable", "terseLabel": "Maximum number of achievable performance stock units" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfShareAchievable", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPerformanceBasedEquityAwardsDetails" ], "xbrltype": "sharesItemType" }, "trhc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available", "label": "Share Based compensation Arrangement By Share Based Payment Award Options Outstanding Aggregate Intrinsic Value [Abstract]", "terseLabel": "Aggregate intrinsic value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueAbstract", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsActivityDetails" ], "xbrltype": "stringItemType" }, "trhc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Share Based compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining contractual Term [Abstract]", "terseLabel": "Weighted average remaining contractual term" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsActivityDetails" ], "xbrltype": "stringItemType" }, "trhc_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfCommonStockDiscount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Discount on purchase price of common stock expressed as a percentage of its fair value.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Discount", "terseLabel": "Discount (as a percent)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfCommonStockDiscount", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationEmployeeStockPurchasePlanDetails" ], "xbrltype": "percentItemType" }, "trhc_ShareBasedPaymentArrangementAcceleratedVestingExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement related to accelerated vesting.", "label": "Share-Based Payment Arrangement, Accelerated Vesting, Expense", "terseLabel": "Accelerated vesting expense" } } }, "localname": "ShareBasedPaymentArrangementAcceleratedVestingExpense", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationRestrictedCommonStockAndRestrictedStockUnitsDetails" ], "xbrltype": "monetaryItemType" }, "trhc_ShareBasedPaymentArrangementExpenseDiscontinuedOperations": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaLossDiscontinuedOperationsDetails": { "order": 7.0, "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement classified as a discontinued operation. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense, Discontinued Operations", "terseLabel": "Stock-based compensation expense" } } }, "localname": "ShareBasedPaymentArrangementExpenseDiscontinuedOperations", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaLossDiscontinuedOperationsDetails" ], "xbrltype": "monetaryItemType" }, "trhc_ShareBasedPaymentArrangementExpenseIncludingDiscontinuedOperations": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized, including discontinued operations.", "label": "Share-based Payment Arrangement, Expense, Including Discontinued Operations", "terseLabel": "Stock-based compensation", "verboseLabel": "Stock-based compensation expense, including discontinued operations (in dollars)" } } }, "localname": "ShareBasedPaymentArrangementExpenseIncludingDiscontinuedOperations", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationExpenseDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsValuationDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOtherStockAwardsDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPerformanceBasedEquityAwardsDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationRestrictedCommonStockAndRestrictedStockUnitsDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "trhc_SharedServicesAndOtherMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shared Services and Other, an operating segment of the entity. Includes continuing operations of the MedWise HealthCare segment.", "label": "Shared Services and Other" } } }, "localname": "SharedServicesAndOtherMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingRevenueDetails" ], "xbrltype": "domainItemType" }, "trhc_SoftwareSubscriptionAndServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to software subscription and services.", "label": "Service - Software subscription and services" } } }, "localname": "SoftwareSubscriptionAndServicesMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRevenueDisaggregationDetails", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingRevenueDetails" ], "xbrltype": "domainItemType" }, "trhc_StockAwardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents other stock awards not otherwise specified in the taxonomy.", "label": "Other stock awards" } } }, "localname": "StockAwardMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOtherStockAwardsDetails" ], "xbrltype": "domainItemType" }, "trhc_StockBasedCompensationDiscontinuedOperations": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of stock-based compensation attributable to discontinued operations.", "label": "Stock-Based Compensation, Discontinued Operations", "terseLabel": "Stock-based compensation" } } }, "localname": "StockBasedCompensationDiscontinuedOperations", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessOperatingNonCashItemsAndInvestingActivitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleOperatingNonCashItemsAndInvestingActivitiesDetails" ], "xbrltype": "monetaryItemType" }, "trhc_StockIssuedDuringPeriodSharesStockOptionsExerciseCashlessExercise": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period, net of the number of shares used by the option holder to pay for the stock option exercise in a cashless transaction.", "label": "Stock Issued During Period, Shares, Stock Options Exercise, Cashless Exercise", "terseLabel": "Exercise of stock options, net of shares withheld (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExerciseCashlessExercise", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "trhc_StockIssuedDuringPeriodValueStockOptionsExercisedCashlessExercise": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options, net of the value of shares used by the option holder to pay for the stock option exercise in a cashless transaction.", "label": "Stock Issued During Period, Value, Stock Options Exercised, Cashless Exercise", "terseLabel": "Exercise of stock options, net of shares withheld" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercisedCashlessExercise", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "trhc_TabulaRasaHealthcareInc.AndKarmadataInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabula Rasa HealthCare, Inc., and karmadata, Inc., a Delaware corporation (\"KD\").", "label": "Tabula Rasa HealthCare, Inc. and karmadata, Inc." } } }, "localname": "TabulaRasaHealthcareInc.AndKarmadataInc.Member", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails" ], "xbrltype": "domainItemType" }, "trhc_TermToReceiveElectronicPaymentOfClaim": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The term over which sponsors are required to remit electronic payment for claims.", "label": "Term to Receive Electronic Payment of Claim", "terseLabel": "Electronic payment term of claims" } } }, "localname": "TermToReceiveElectronicPaymentOfClaim", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsConcentrationsDetails" ], "xbrltype": "durationItemType" }, "trhc_TermToReceiveNonelectronicPaymentOfClaim": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The term over which sponsors are required to remit nonelectronic payment for claims.", "label": "Term to Receive Nonelectronic Payment of Claim", "terseLabel": "Nonelectronic payment term of claims" } } }, "localname": "TermToReceiveNonelectronicPaymentOfClaim", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsConcentrationsDetails" ], "xbrltype": "durationItemType" }, "trhc_ThriftyDrugStoresInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Thrifty Drug Stores, Inc.", "label": "Thrifty Drug Stores, Inc." } } }, "localname": "ThriftyDrugStoresInc.Member", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureCommitmentsAndContingenciesVendorPurchaseAgreementsDetails" ], "xbrltype": "domainItemType" }, "trhc_TransactionDataSystemsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transaction Data Systems, Inc. (\"TDS\").", "label": "TDS" } } }, "localname": "TransactionDataSystemsInc.Member", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails" ], "xbrltype": "domainItemType" }, "trhc_TransitionServicesAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transition services agreement to provide certain services including but not limited to, business support services following disposal of business.", "label": "Transition Services Agreement" } } }, "localname": "TransitionServicesAgreementMember", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails" ], "xbrltype": "domainItemType" }, "trhc_VendorFinancingArrangements": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of vendor financing arrangements.", "label": "Vendor Financing Arrangements", "terseLabel": "Vendor Financing Arrangements, Outstanding principal balance" } } }, "localname": "VendorFinancingArrangements", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsVendorFinancingArrangementsDetails" ], "xbrltype": "monetaryItemType" }, "trhc_VendorFinancingArrangementsCurrent": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureAccruedExpensesAndOtherLiabilitiesDetails": { "order": 8.0, "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of vendor financing arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Vendor Financing Arrangements, Current", "terseLabel": "Vendor financing arrangements" } } }, "localname": "VendorFinancingArrangementsCurrent", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureAccruedExpensesAndOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "trhc_VendorFinancingArrangementsImputedInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rate of imputed interest on vendor financing arrangements.", "label": "Vendor Financing Arrangements, Imputed Interest Rate", "terseLabel": "Vendor Financing Arrangements, Imputed interest rate (as a percent)" } } }, "localname": "VendorFinancingArrangementsImputedInterestRate", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsVendorFinancingArrangementsDetails" ], "xbrltype": "percentItemType" }, "trhc_VendorFinancingArrangementsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for vendor financing arrangements.", "label": "Vendor Financing Arrangements [Policy Text Block]", "terseLabel": "Vendor Financing Arrangements" } } }, "localname": "VendorFinancingArrangementsPolicyTextBlock", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies" ], "xbrltype": "textBlockItemType" }, "trhc_VendorFinancingArrangementsUnamortizedDiscountTotal": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of vendor financing arrangement discount.", "label": "Vendor Financing Arrangements, Unamortized Discount, Total", "terseLabel": "Vendor Financing Arrangements, Unamortized discount" } } }, "localname": "VendorFinancingArrangementsUnamortizedDiscountTotal", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsVendorFinancingArrangementsDetails" ], "xbrltype": "monetaryItemType" }, "trhc_WarrantsExercisesInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares of stock issued as a result of the exercise of warrants.", "label": "Warrants Exercises In Period", "verboseLabel": "Warrants exercised" } } }, "localname": "WarrantsExercisesInPeriod", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleNoteHedgeAndWarrantTransactionsDetails" ], "xbrltype": "sharesItemType" }, "trhc_WeightedAverageNumberOfSharesOutstandingDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "No definition available.", "label": "Weighted Average Number Of Shares Outstanding Disclosure [Abstract]", "verboseLabel": "Denominator (basic and diluted):" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingDisclosureAbstract", "nsuri": "http://www.tabularasahealthcare.com/20220930", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareEpsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basis of Presentation, Summary of Significant Accounting Policies, and Recent Accounting Pronouncements" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.", "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]", "terseLabel": "Accrued Expenses and Other Liabilities" } } }, "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureAccruedExpensesAndOtherLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r58", "r528" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableCurrentAndNoncurrent": { "auth_ref": [ "r551", "r569" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Accounts Payable", "terseLabel": "Amount due as a result of prescription drug purchases" } } }, "localname": "AccountsPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureCommitmentsAndContingenciesVendorPurchaseAgreementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r216", "r217" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, Net, Current", "terseLabel": "Accounts receivable, net of allowance of $107 and $110, respectively" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableRelatedParties": { "auth_ref": [ "r47", "r125", "r520", "r523", "r567" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For an unclassified balance sheet, amount of receivables arising from transactions with related parties.", "label": "Accounts Receivable, Related Parties", "terseLabel": "Accounts receivable from related parties" } } }, "localname": "AccountsReceivableRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesAndOtherLiabilities": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureAccruedExpensesAndOtherLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.", "label": "Accrued Liabilities and Other Liabilities.", "terseLabel": "Accrued expenses and other liabilities", "totalLabel": "Total accrued expenses and other liabilities" } } }, "localname": "AccruedLiabilitiesAndOtherLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureAccruedExpensesAndOtherLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accrued Expenses and Other Liabilities" } } }, "localname": "AccruedLiabilitiesAndOtherLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r62" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureAccruedExpensesAndOtherLiabilitiesDetails": { "order": 9.0, "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Professional Fees, Current", "terseLabel": "Professional fees" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureAccruedExpensesAndOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r239" ], "lang": { "en-us": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life", "verboseLabel": "Weighted Average Amortization Period" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental disclosure of cash flow information:" } } }, "localname": "AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r48", "r528" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r130", "r131", "r132", "r429", "r430", "r431", "r482" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation", "negatedLabel": "Shares withheld for payment of employee taxes", "terseLabel": "Shares paid for tax withholding, fair value" } } }, "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsActivityDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.", "label": "Adjustments to Additional Paid in Capital, Share-based Compensation, Stock Options, Requisite Service Period Recognition", "terseLabel": "Stock-based compensation expense" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "Adjustments to reconcile net loss to net cash provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r422" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails": { "order": 11.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Allocated Share-based Compensation Expense", "verboseLabel": "Stock- based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r53", "r218", "r222" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "terseLabel": "Allowance for accounts receivable" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r92", "r110", "r313", "r508" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of Debt Discount (Premium)", "terseLabel": "Non-cash accretion of discounts" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleSeniorSubordinatedNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r86", "r110", "r313", "r510" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of Debt Issuance Costs", "terseLabel": "Amortization of deferred financing costs to interest expense" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLineOfCreditDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "auth_ref": [ "r110", "r313", "r326", "r327", "r510" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.", "label": "Amortization of Debt Issuance Costs and Discounts", "terseLabel": "Amortization of deferred financing costs and debt discount" } } }, "localname": "AmortizationOfFinancingCostsAndDiscounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r110", "r237", "r244" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization expense" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r160" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Amount of antidilutive securities excluded from computation of earnings per share" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareAntiDilutiveSecuritiesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r160" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareAntiDilutiveSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Securities excluded from the calculation of diluted net loss per share attributable to common stockholders" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareAntiDilutiveSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r160" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareAntiDilutiveSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r110", "r249" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails": { "order": 4.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 }, "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Asset Impairment Charges", "terseLabel": "Long-lived asset impairment charge", "verboseLabel": "Impairment charges" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails", "http://www.tabularasahealthcare.com/role/DisclosureSoftwareDevelopmentCostsDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r39", "r122", "r191", "r198", "r205", "r220", "r274", "r275", "r276", "r278", "r279", "r280", "r281", "r283", "r285", "r287", "r288", "r463", "r468", "r499", "r526", "r528", "r547", "r563" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r33", "r57", "r122", "r220", "r274", "r275", "r276", "r278", "r279", "r280", "r281", "r283", "r285", "r287", "r288", "r463", "r468", "r499", "r526", "r528" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "auth_ref": [ "r1", "r2", "r21", "r23", "r27", "r250", "r254" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Assets, Current", "terseLabel": "Current assets of discontinued operations", "totalLabel": "Total current assets of discontinued operations" } } }, "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Assets, Current [Abstract]", "terseLabel": "Current assets of discontinued operations" } } }, "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Assets, Noncurrent [Abstract]", "terseLabel": "Noncurrent assets of discontinued operations" } } }, "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateAxis": { "auth_ref": [ "r390", "r391", "r392", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r403", "r404", "r405", "r406", "r407", "r408", "r410", "r411", "r413", "r414", "r416", "r417", "r418", "r419", "r420" ], "lang": { "en-us": { "role": { "documentation": "Information by date or year award under share-based payment arrangement is granted.", "label": "Award Date [Axis]" } } }, "localname": "AwardDateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOtherStockAwardsDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPerformanceBasedEquityAwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateDomain": { "auth_ref": [ "r390", "r391", "r392", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r403", "r404", "r405", "r406", "r407", "r408", "r410", "r411", "r413", "r414", "r416", "r417", "r418", "r419", "r420" ], "lang": { "en-us": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted.", "label": "Award Date [Domain]" } } }, "localname": "AwardDateDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOtherStockAwardsDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPerformanceBasedEquityAwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r390", "r391", "r392", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r403", "r404", "r405", "r406", "r407", "r408", "r410", "r411", "r413", "r414", "r416", "r417", "r418", "r419", "r420" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationEmployeeStockPurchasePlanDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsActivityDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsValuationDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOtherStockAwardsDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPerformanceBasedEquityAwardsDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationRestrictedCommonStockAndRestrictedStockUnitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsCloudComputingArrangementsDetails", "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsVendorFinancingArrangementsDetails", "http://www.tabularasahealthcare.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r472", "r473" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsCloudComputingArrangementsDetails", "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsVendorFinancingArrangementsDetails", "http://www.tabularasahealthcare.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "auth_ref": [ "r453" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails": { "order": 10.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Business Combination, Acquisition Related Costs", "verboseLabel": "Acquisition-related expense" } } }, "localname": "BusinessCombinationAcquisitionRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationAssetNoncurrent": { "auth_ref": [ "r458", "r459" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset recognized arising from contingent consideration in a business combination, expected to be realized beyond one year or the normal operating cycle, if longer.", "label": "Business Combination, Contingent Consideration, Asset, Noncurrent", "terseLabel": "Contingent consideration receivable" } } }, "localname": "BusinessCombinationContingentConsiderationAssetNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails", "http://www.tabularasahealthcare.com/role/DisclosureFairValueMeasurementsFinancialInstrumentsDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CallOptionMember": { "auth_ref": [ "r588", "r589", "r590", "r591", "r592", "r593" ], "lang": { "en-us": { "role": { "documentation": "Financial contract between two parties, the buyer and the seller of the option, where the buyer has the right but not the obligation to buy an agreed quantity of a particular commodity or financial instrument (the underlying instrument) from the seller of the option for a certain price (the strike price). Seller is obligated to sell the asset to the buyer, if the buyer exercises the option.", "label": "Convertible senior subordinated notes, Option to purchase shares" } } }, "localname": "CallOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleNoteHedgeAndWarrantTransactionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CapitalExpenditureDiscontinuedOperations": { "auth_ref": [ "r19" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of capital expenditure attributable to discontinued operations.", "label": "Capital Expenditure, Discontinued Operations", "negatedLabel": "Purchases of property and equipment" } } }, "localname": "CapitalExpenditureDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessOperatingNonCashItemsAndInvestingActivitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleOperatingNonCashItemsAndInvestingActivitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "auth_ref": [ "r114", "r115", "r116" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.", "label": "Capital Expenditures Incurred but Not yet Paid", "terseLabel": "Purchases of property and equipment and software development included in accounts payable and accrued expenses" } } }, "localname": "CapitalExpendituresIncurredButNotYetPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedComputerSoftwareAmortization1": { "auth_ref": [ "r601", "r603" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for amortization of capitalized computer software costs.", "label": "Capitalized Computer Software, Amortization", "terseLabel": "Amortization expense" } } }, "localname": "CapitalizedComputerSoftwareAmortization1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSoftwareDevelopmentCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedComputerSoftwareNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Software Development Costs" } } }, "localname": "CapitalizedComputerSoftwareNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CarryingReportedAmountFairValueDisclosureMember": { "auth_ref": [ "r494", "r495" ], "lang": { "en-us": { "role": { "documentation": "Measured as reported on the statement of financial position (balance sheet).", "label": "Carrying Value" } } }, "localname": "CarryingReportedAmountFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureFairValueMeasurementsFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r30", "r35", "r112" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlowsParenthetical": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlowsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r106", "r112", "r117" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlowsParenthetical": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash and restricted cash, end of period", "periodStartLabel": "Cash and restricted cash, beginning of period", "totalLabel": "Total cash and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlowsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r106", "r500" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase (decrease) in cash and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashIncludingDiscontinuedOperations": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlowsParenthetical": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Includes cash within disposal group or discontinued operation.", "label": "Cash, Including Discontinued Operations", "terseLabel": "Cash from discontinued operations" } } }, "localname": "CashIncludingDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlowsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_ChangeInContractWithCustomerAssetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Change in Contract with Customer, Asset [Abstract]", "terseLabel": "Contract assets:" } } }, "localname": "ChangeInContractWithCustomerAssetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRevenueChangeInContractBalancesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ChangeInContractWithCustomerLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Change in Contract with Customer, Liability [Abstract]", "terseLabel": "Contract liabilities:" } } }, "localname": "ChangeInContractWithCustomerLiabilityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRevenueChangeInContractBalancesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r43", "r44", "r45", "r120", "r122", "r148", "r149", "r154", "r157", "r159", "r167", "r168", "r169", "r220", "r274", "r279", "r280", "r281", "r287", "r288", "r331", "r332", "r335", "r336", "r337", "r499", "r610" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRightsPlanDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r346", "r388" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleNoteHedgeAndWarrantTransactionsDetails", "http://www.tabularasahealthcare.com/role/DisclosureRightsPlanDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleNoteHedgeAndWarrantTransactionsDetails", "http://www.tabularasahealthcare.com/role/DisclosureRightsPlanDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Exercise price (in dollars per share)", "verboseLabel": "Exercise price (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleNoteHedgeAndWarrantTransactionsDetails", "http://www.tabularasahealthcare.com/role/DisclosureRightsPlanDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Warrant or Right [Line Items]", "verboseLabel": "Right" } } }, "localname": "ClassOfWarrantOrRightLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRightsPlanDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.", "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right", "terseLabel": "Number of shares of stock per each right" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRightsPlanDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "terseLabel": "Option to purchase" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleNoteHedgeAndWarrantTransactionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightTable": { "auth_ref": [ "r346", "r388" ], "lang": { "en-us": { "role": { "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Class of Warrant or Right [Table]" } } }, "localname": "ClassOfWarrantOrRightTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRightsPlanDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r69", "r552", "r568" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies.", "terseLabel": "Commitments and contingencies (Note 15)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r263", "r264", "r265", "r271", "r595" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "verboseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureCommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r70" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common Stock, Capital Shares Reserved for Future Issuance", "terseLabel": "Number of shares reserved for issuance" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationEmployeeStockPurchasePlanDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r130", "r131", "r482" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r45" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r45" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r45" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r45", "r337" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r45", "r528" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.0001 par value; 100,000,000 shares authorized, 27,967,305 and 26,036,236 shares issued and 27,081,443 and 25,666,434 shares outstanding at September 30, 2022 and December 31, 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r174", "r175", "r213", "r496", "r497", "r594" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r174", "r175", "r213", "r496", "r497", "r586", "r594" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r174", "r175", "r213", "r496", "r497", "r586", "r594" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r171", "r561" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]", "terseLabel": "Concentration Risk" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r174", "r175", "r213", "r496", "r497" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Concentration risk (as a percent)" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsConcentrationsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r172", "r174", "r175", "r176", "r496", "r498", "r594" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r174", "r175", "r213", "r496", "r497", "r594" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contract with Customer, Asset and Liability [Abstract]", "terseLabel": "Contract Balances" } } }, "localname": "ContractWithCustomerAssetAndLiabilityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRevenueContractBalancesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ContractWithCustomerAssetNetCurrent": { "auth_ref": [ "r347", "r349", "r360" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureOtherCurrentAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.", "label": "Contract with Customer, Asset, Net, Current", "periodEndLabel": "Contract assets, end of period", "periodStartLabel": "Contract assets, beginning of period", "terseLabel": "Contract assets" } } }, "localname": "ContractWithCustomerAssetNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureOtherCurrentAssetsDetails", "http://www.tabularasahealthcare.com/role/DisclosureRevenueChangeInContractBalancesDetails", "http://www.tabularasahealthcare.com/role/DisclosureRevenueContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r347", "r348", "r360" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "periodEndLabel": "Contract liabilities, end of period", "periodStartLabel": "Contract liabilities, beginning of period", "terseLabel": "Contract liabilities" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRevenueChangeInContractBalancesDetails", "http://www.tabularasahealthcare.com/role/DisclosureRevenueContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r361" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Revenue Recognized", "negatedLabel": "Revenue recognized that was included in the contract liabilities balance at the beginning of the period" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRevenueChangeInContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtMember": { "auth_ref": [ "r289", "r290", "r291", "r293", "r303", "r304", "r305", "r309", "r310", "r311", "r312", "r313", "r324", "r325", "r326", "r327" ], "lang": { "en-us": { "role": { "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt" } } }, "localname": "ConvertibleDebtMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareAntiDilutiveSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CorporateNonSegmentMember": { "auth_ref": [ "r196", "r197", "r198", "r199", "r201", "r207", "r209" ], "lang": { "en-us": { "role": { "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.", "label": "Shared Services and Others" } } }, "localname": "CorporateNonSegmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingEbitdaDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSoldAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cost of Goods and Services Sold [Abstract]", "terseLabel": "Cost of revenue, exclusive of depreciation and amortization shown below:" } } }, "localname": "CostOfGoodsAndServicesSoldAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r89", "r122", "r220", "r274", "r275", "r276", "r279", "r280", "r281", "r283", "r285", "r287", "r288", "r499" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "terseLabel": "Total cost of revenue, exclusive of depreciation and amortization" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditConcentrationRiskMember": { "auth_ref": [ "r498" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that a specified receivable or amount at risk from a counterparty under a contractual arrangement is to a specified benchmark, such as total receivables, net revenues, pretax results. Risk is the materially adverse effects of loss attributable to (a) the failure to collect a significant receivable from a major customer or group of homogeneous accounts, or (b) a failure by a counterparty to perform under terms of a contractual arrangement.", "label": "Credit risk" } } }, "localname": "CreditConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r173", "r213" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer risk" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r456" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Client relationships" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lines of Credit and Long-Term Debt" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r119", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r307", "r314", "r315", "r317", "r328" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Line of Credit and Long-Term Debt" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r40", "r41", "r42", "r121", "r128", "r290", "r291", "r292", "r293", "r294", "r295", "r297", "r303", "r304", "r305", "r306", "r308", "r309", "r310", "r311", "r312", "r313", "r324", "r325", "r326", "r327", "r511", "r548", "r549", "r562" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureFairValueMeasurementsFinancialInstrumentsDetails", "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleSeniorSubordinatedNotesDetails", "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLineOfCreditDetails", "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLongTermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Spread on variable rate (as a percent)" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLineOfCreditDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r42", "r318", "r549", "r562" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLongTermDebtDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-term Debt, Gross", "terseLabel": "Convertible senior subordinated notes" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r292", "r321" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Initial conversion price (in dollars per share)" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleSeniorSubordinatedNotesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentConvertibleConversionRatio1": { "auth_ref": [ "r65", "r292", "r338", "r339", "r341" ], "lang": { "en-us": { "role": { "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.", "label": "Debt Instrument, Convertible, Conversion Ratio", "terseLabel": "Initial conversion rate" } } }, "localname": "DebtInstrumentConvertibleConversionRatio1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleSeniorSubordinatedNotesDetails" ], "xbrltype": "pureItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.", "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days", "terseLabel": "Consecutive trading days" } } }, "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleSeniorSubordinatedNotesDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.", "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger", "terseLabel": "Stock price trigger percentage (as a percent)" } } }, "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleSeniorSubordinatedNotesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.", "label": "Debt Instrument, Convertible, Threshold Trading Days", "verboseLabel": "Trading days" } } }, "localname": "DebtInstrumentConvertibleThresholdTradingDays", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleSeniorSubordinatedNotesDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r290", "r324", "r325", "r509", "r511", "r512" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Aggregate borrowings", "verboseLabel": "Face value" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureFairValueMeasurementsFinancialInstrumentsDetails", "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleSeniorSubordinatedNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [ "r305", "r324", "r325", "r493" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.", "label": "Debt Instrument, Fair Value Disclosure", "terseLabel": "Debt instrument" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureFairValueMeasurementsFinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r64", "r322", "r509", "r511" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument, Interest Rate, Effective Percentage", "verboseLabel": "Effective interest rate" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleSeniorSubordinatedNotesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r64", "r291" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Interest rate (as a percent)" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureFairValueMeasurementsFinancialInstrumentsDetails", "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleSeniorSubordinatedNotesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Lines of Credit and Long-Term Debt", "verboseLabel": "Long-Term Debt" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleSeniorSubordinatedNotesDetails", "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLineOfCreditDetails", "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLongTermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r66", "r121", "r128", "r290", "r291", "r292", "r293", "r294", "r295", "r297", "r303", "r304", "r305", "r306", "r308", "r309", "r310", "r311", "r312", "r313", "r324", "r325", "r326", "r327", "r511" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureFairValueMeasurementsFinancialInstrumentsDetails", "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleSeniorSubordinatedNotesDetails", "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLineOfCreditDetails", "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r66", "r121", "r128", "r290", "r291", "r292", "r293", "r294", "r295", "r297", "r303", "r304", "r305", "r306", "r308", "r309", "r310", "r311", "r312", "r313", "r316", "r324", "r325", "r326", "r327", "r338", "r340", "r341", "r342", "r508", "r509", "r511", "r512", "r560" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleSeniorSubordinatedNotesDetails", "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLineOfCreditDetails", "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLongTermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": { "auth_ref": [ "r303", "r319", "r324", "r325", "r510" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLongTermDebtDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.", "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net", "negatedLabel": "Unamortized discount, including debt issuance costs, on convertible senior subordinated notes" } } }, "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsGross": { "auth_ref": [ "r510" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Gross", "terseLabel": "Deferred financing costs, gross" } } }, "localname": "DeferredFinanceCostsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLineOfCreditDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r303", "r510" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Net", "verboseLabel": "Debt issuance costs" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleSeniorSubordinatedNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r435", "r436" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "terseLabel": "Deferred income tax liability, net" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxesAndTaxCredits": { "auth_ref": [ "r111" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.", "label": "Deferred Income Taxes and Tax Credits", "terseLabel": "Deferred taxes" } } }, "localname": "DeferredIncomeTaxesAndTaxCredits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAmortizationAndAccretionNet": { "auth_ref": [ "r110" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails": { "order": 3.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 }, "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Depreciation, Amortization and Accretion, Net", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAmortizationAndAccretionNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosurePropertyAndEquipmentDetails", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortizationDiscontinuedOperations": { "auth_ref": [ "r19", "r110" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaLossDiscontinuedOperationsDetails": { "order": 2.0, "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deprecation and amortization expense attributable to property, plant and equipment and intangible assets of discontinued operations.", "label": "Depreciation and Amortization, Discontinued Operations", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortizationDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessOperatingNonCashItemsAndInvestingActivitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleOperatingNonCashItemsAndInvestingActivitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaLossDiscontinuedOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DevelopedTechnologyRightsMember": { "auth_ref": [ "r457" ], "lang": { "en-us": { "role": { "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.", "label": "Developed technology" } } }, "localname": "DevelopedTechnologyRightsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Disaggregation of revenue" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRevenueDisaggregationDetails", "http://www.tabularasahealthcare.com/role/DisclosureRevenueGeneralDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r359", "r363", "r364", "r365", "r366", "r367", "r368", "r369" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRevenueDisaggregationDetails", "http://www.tabularasahealthcare.com/role/DisclosureRevenueGeneralDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r359" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Schedule of disaggregation of revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r389", "r390", "r423", "r424", "r426", "r433" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Disclosure of Compensation Related Costs, Share-based Payments [Text Block]", "terseLabel": "Stock-Based Compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock-Based Compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DiscontinuedOperationAlternativeCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Discontinued Operation, Alternative Cash Flow Information [Abstract]", "terseLabel": "Operating non-cash items and investing activities of discontinued operations:" } } }, "localname": "DiscontinuedOperationAlternativeCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessOperatingNonCashItemsAndInvestingActivitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleOperatingNonCashItemsAndInvestingActivitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTaxAttributableToParent": { "auth_ref": [ "r20" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessResultsOfOperationsDetails": { "order": 1.0, "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of income (loss) from operations classified as a discontinued operation attributable to the parent. Excludes gain (loss) on disposal and provision for gain (loss) until its disposal.", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax, Attributable to Parent", "totalLabel": "Loss from discontinued operations before income taxes" } } }, "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTaxAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessResultsOfOperationsDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleResultsOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax": { "auth_ref": [ "r9", "r10", "r24" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessResultsOfOperationsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails": { "order": 12.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 }, "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaLossDiscontinuedOperationsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until disposal.", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax", "negatedLabel": "Loss from discontinued operations", "terseLabel": "Net loss from discontinued operations, net of tax", "totalLabel": "Net loss from discontinued operations, net of tax" } } }, "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessResultsOfOperationsDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleResultsOfOperationsDetails", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaLossDiscontinuedOperationsDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_EarningsPerShareBasic", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share", "terseLabel": "Net loss per share from discontinued operations, basic (in dollars per share)" } } }, "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareEpsDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_EarningsPerShareDiluted", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share", "terseLabel": "Net loss per share from discontinued operations, diluted (in dollars per share)" } } }, "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareEpsDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod": { "auth_ref": [ "r10", "r24", "r449" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessResultsOfOperationsDetails": { "order": 2.0, "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax", "weight": -1.0 }, "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaLossDiscontinuedOperationsDetails": { "order": 1.0, "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) attributable to income (loss) from operations classified as a discontinued operation. Excludes tax expense (benefit) for gain (loss) on disposal and for provision for gain (loss) until disposal.", "label": "Discontinued Operation, Tax Effect of Income (Loss) from Discontinued Operation During Phase-out Period", "terseLabel": "Income tax (benefit) expense" } } }, "localname": "DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessResultsOfOperationsDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleResultsOfOperationsDetails", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaLossDiscontinuedOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Discontinued Operations" } } }, "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DiscontinuedOperationsDisposedOfBySaleMember": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Component or group of components disposed of by sale and representing a strategic shift that has or will have a major effect on operations and financial results.", "label": "Discontinued Operations, Disposed of by Sale" } } }, "localname": "DiscontinuedOperationsDisposedOfBySaleMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessOperatingNonCashItemsAndInvestingActivitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessResultsOfOperationsDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsTables" ], "xbrltype": "domainItemType" }, "us-gaap_DiscontinuedOperationsHeldforsaleMember": { "auth_ref": [ "r4", "r8", "r23" ], "lang": { "en-us": { "role": { "documentation": "Component or group of components classified as held-for-sale and representing a strategic shift that has or will have a major effect on operations and financial results. Includes a business or nonprofit activity on acquisition classified as held-for-sale.", "label": "Discontinued Operations, Held-for-sale" } } }, "localname": "DiscontinuedOperationsHeldforsaleMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessOperatingNonCashItemsAndInvestingActivitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessResultsOfOperationsDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleOperatingNonCashItemsAndInvestingActivitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleResultsOfOperationsDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsTables", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaLossDiscontinuedOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DiscontinuedOperationsPolicyTextBlock": { "auth_ref": [ "r12", "r28" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for discontinued operations. Includes, but is not limited to, method of interest allocation to a discontinued operation.", "label": "Discontinued Operations, Policy [Policy Text Block]", "terseLabel": "Assets and Liabilities Held for Sale and Discontinued Operations" } } }, "localname": "DiscontinuedOperationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisposalGroupClassificationAxis": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "Information by disposal group classification.", "label": "Disposal Group Classification [Axis]" } } }, "localname": "DisposalGroupClassificationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessOperatingNonCashItemsAndInvestingActivitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessResultsOfOperationsDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleOperatingNonCashItemsAndInvestingActivitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleResultsOfOperationsDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsTables", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaLossDiscontinuedOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupClassificationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.", "label": "Disposal Group Classification [Domain]" } } }, "localname": "DisposalGroupClassificationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessOperatingNonCashItemsAndInvestingActivitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessResultsOfOperationsDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleOperatingNonCashItemsAndInvestingActivitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleResultsOfOperationsDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsTables", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaLossDiscontinuedOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": { "auth_ref": [ "r1", "r2", "r21", "r254" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net", "terseLabel": "Accounts receivable, net" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent": { "auth_ref": [ "r1", "r2", "r21", "r250", "r254" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as accounts payable attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent": { "auth_ref": [ "r1", "r2", "r21", "r23", "r27", "r248", "r254" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Assets, Noncurrent", "terseLabel": "Noncurrent assets of discontinued operations", "totalLabel": "Total noncurrent assets of discontinued operations" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": { "auth_ref": [ "r1", "r2", "r21", "r254" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents", "terseLabel": "Cash" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationClassifiedBalanceSheetDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Classified Balance Sheet Disclosures [Abstract]", "terseLabel": "Current and noncurrent assets and liabilities classified as discontinued operations" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationClassifiedBalanceSheetDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold": { "auth_ref": [ "r18", "r27" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessResultsOfOperationsDetails": { "order": 2.0, "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTaxAttributableToParent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Costs of Goods Sold", "terseLabel": "Cost of revenue, exclusive of depreciation and amortization" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessResultsOfOperationsDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleResultsOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent": { "auth_ref": [ "r1", "r2", "r21", "r250", "r254" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails": { "order": 9.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Goodwill, Current", "terseLabel": "Goodwill" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent": { "auth_ref": [ "r1", "r2", "r21", "r248", "r254" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Goodwill, Noncurrent", "terseLabel": "Goodwill" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent": { "auth_ref": [ "r1", "r2", "r21", "r250", "r254" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Intangible Assets, Current", "terseLabel": "Intangible assets, net" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent": { "auth_ref": [ "r1", "r2", "r21", "r248", "r254" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Intangible Assets, Noncurrent", "terseLabel": "Intangible assets, net" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense": { "auth_ref": [ "r18" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessResultsOfOperationsDetails": { "order": 3.0, "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTaxAttributableToParent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Operating Expense", "terseLabel": "Operating expenses" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessResultsOfOperationsDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleResultsOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets": { "auth_ref": [ "r1", "r2", "r21", "r248", "r254" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent", "terseLabel": "Other assets" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities": { "auth_ref": [ "r1", "r2", "r21", "r248", "r254" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Other Liabilities, Noncurrent", "terseLabel": "Other long-term liabilities" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent": { "auth_ref": [ "r1", "r2", "r21", "r250", "r254" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current", "terseLabel": "Prepaid expenses and other assets" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent": { "auth_ref": [ "r1", "r2", "r21", "r250", "r254" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Current", "terseLabel": "Property and equipment, net" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent": { "auth_ref": [ "r1", "r2", "r21", "r248", "r254" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Noncurrent", "terseLabel": "Property and equipment, net" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": { "auth_ref": [ "r18", "r27" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessResultsOfOperationsDetails": { "order": 1.0, "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTaxAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Revenue", "terseLabel": "Revenue" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessResultsOfOperationsDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleResultsOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]", "terseLabel": "Loss from discontinued operations" } } }, "localname": "DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessResultsOfOperationsDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleResultsOfOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": { "auth_ref": [ "r29", "r258" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]", "terseLabel": "Discontinued Operations" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "auth_ref": [ "r381", "r384" ], "lang": { "en-us": { "role": { "documentation": "Name of disposal group.", "label": "Disposal Group Name [Domain]" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessOperatingNonCashItemsAndInvestingActivitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessResultsOfOperationsDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleOperatingNonCashItemsAndInvestingActivitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleResultsOfOperationsDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsTables", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaLossDiscontinuedOperationsDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlowsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r58", "r125", "r277", "r279", "r280", "r286", "r287", "r288", "r520" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Due to Related Parties, Current", "terseLabel": "Amount due to related party" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Loss per Share" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r84", "r136", "r137", "r138", "r139", "r140", "r145", "r148", "r157", "r158", "r159", "r163", "r164", "r483", "r484", "r557", "r573" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "totalLabel": "Total net loss per share, basic (in dollars per share)", "verboseLabel": "Total net loss per share, basic (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareEpsDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r84", "r136", "r137", "r138", "r139", "r140", "r148", "r157", "r158", "r159", "r163", "r164", "r483", "r484", "r557", "r573" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "totalLabel": "Total net loss per share, diluted (in dollars per share)", "verboseLabel": "Total net loss per share, diluted (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareEpsDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r160", "r161", "r162", "r165" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Net Loss per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r438" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Effective tax rate (as a percent)" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureIncomeTaxesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r62" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureAccruedExpensesAndOtherLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Employee related expenses" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureAccruedExpensesAndOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]", "terseLabel": "Stock-based compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r425" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized", "terseLabel": "Unrecognized compensation expense (in dollars)", "verboseLabel": "Unrecognized compensation cost (in dollars)" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsActivityDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPerformanceBasedEquityAwardsDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationRestrictedCommonStockAndRestrictedStockUnitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r425" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition", "terseLabel": "Weighted average period expected to be recognized" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsActivityDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationRestrictedCommonStockAndRestrictedStockUnitsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.", "label": "Employee Stock Purchase Plan" } } }, "localname": "EmployeeStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationEmployeeStockPurchasePlanDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Stock options" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareAntiDilutiveSecuritiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsActivityDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsValuationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r78", "r79", "r80", "r130", "r131", "r132", "r135", "r141", "r143", "r166", "r221", "r337", "r343", "r429", "r430", "r431", "r443", "r444", "r482", "r501", "r502", "r503", "r504", "r505", "r506", "r516", "r581", "r582", "r583" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "auth_ref": [ "r305", "r324", "r325", "r493" ], "lang": { "en-us": { "role": { "documentation": "Measured as an estimate of fair value.", "label": "Fair Value" } } }, "localname": "EstimateOfFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureFairValueMeasurementsFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ExtinguishmentOfDebtAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount of debt extinguished.", "label": "Extinguishment of Debt, Amount", "terseLabel": "Repayment of principal and interest" } } }, "localname": "ExtinguishmentOfDebtAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLineOfCreditDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureFairValueMeasurementsFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r485", "r486", "r490" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureFairValueMeasurementsFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r487", "r490" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Schedule of assets measured at fair value on a recurring basis" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r305", "r324", "r325", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r380", "r486", "r531", "r532", "r533" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureFairValueMeasurementsFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementBasisAxis": { "auth_ref": [ "r305", "r324", "r325", "r485", "r491" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement basis.", "label": "Measurement Basis [Axis]" } } }, "localname": "FairValueByMeasurementBasisAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureFairValueMeasurementsFinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock": { "auth_ref": [ "r489" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information about fair value of asset and liability not measured at fair value.", "label": "Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table Text Block]", "terseLabel": "Schedule of financial instruments not carried at fair value" } } }, "localname": "FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r488" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureFairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r305", "r324", "r325", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r380", "r486", "r533" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureFairValueMeasurementsFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r305", "r324", "r325", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r380", "r531", "r532", "r533" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureFairValueMeasurementsFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r37", "r243" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsIntangibleAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsAmortizationDetails": { "order": 7.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Assets, Amortization Expense, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r245" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsAmortizationDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months", "terseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsAmortizationDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year", "terseLabel": "2022 (October 1 - December 31)" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r245" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsAmortizationDetails": { "order": 6.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Five", "terseLabel": "2027" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r245" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsAmortizationDetails": { "order": 5.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Four", "terseLabel": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r245" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsAmortizationDetails": { "order": 4.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Three", "terseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r245" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsAmortizationDetails": { "order": 3.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Two", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsAmortizationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r238", "r240", "r243", "r246", "r543", "r544" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]", "terseLabel": "Estimated amortization expense" } } }, "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsAmortizationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r243", "r544" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsIntangibleAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Gross Value" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Intangible Assets" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r238", "r242" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r243", "r543" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsAmortizationDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "terseLabel": "Intangible Assets, net", "totalLabel": "Total estimated amortization expense" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsAmortizationDetails", "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfBusiness": { "auth_ref": [ "r110", "r467" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessResultsOfOperationsDetails": { "order": 5.0, "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTaxAttributableToParent", "weight": 1.0 }, "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaLossDiscontinuedOperationsDetails": { "order": 4.0, "parentTag": "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax", "weight": 1.0 }, "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.", "label": "Gain (Loss) on Disposition of Business", "negatedLabel": "Loss on divestiture of business" } } }, "localname": "GainLossOnSaleOfBusiness", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessOperatingNonCashItemsAndInvestingActivitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessResultsOfOperationsDetails", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaLossDiscontinuedOperationsDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r90" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "auth_ref": [ "r85" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing general and administrative expense.", "label": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r36", "r225", "r226", "r233", "r235", "r528", "r546" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsGoodwillDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r247" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "terseLabel": "Goodwill and Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill [Roll Forward]", "terseLabel": "Goodwill and related changes" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeLossFromContinuingOperations": { "auth_ref": [ "r88", "r111", "r136", "r137", "r138", "r139", "r155", "r159", "r461" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.", "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent", "totalLabel": "Net loss from continuing operations" } } }, "localname": "IncomeLossFromContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r82", "r191", "r197", "r201", "r204", "r207", "r545", "r554", "r559", "r574" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Loss from continuing operations before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": { "auth_ref": [ "r81", "r84", "r134", "r136", "r137", "r138", "r139", "r148", "r157", "r158", "r484", "r553", "r555", "r557", "r570" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_EarningsPerShareBasic", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.", "label": "Income (Loss) from Continuing Operations, Per Basic Share", "terseLabel": "Net loss per share from continuing operations, basic (in dollars per share)" } } }, "localname": "IncomeLossFromContinuingOperationsPerBasicShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareEpsDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": { "auth_ref": [ "r81", "r84", "r134", "r136", "r137", "r138", "r139", "r148", "r157", "r158", "r159", "r484", "r557", "r570", "r572", "r573" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_EarningsPerShareDiluted", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Income (Loss) from Continuing Operations, Per Diluted Share", "terseLabel": "Net loss per share from continuing operations, diluted (in dollars per share)" } } }, "localname": "IncomeLossFromContinuingOperationsPerDilutedShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareEpsDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF OPERATIONS" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "auth_ref": [ "r381", "r384" ], "lang": { "en-us": { "role": { "documentation": "Information by name of disposal group.", "label": "Disposal Group Name [Axis]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessOperatingNonCashItemsAndInvestingActivitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessResultsOfOperationsDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleOperatingNonCashItemsAndInvestingActivitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleResultsOfOperationsDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsTables", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaLossDiscontinuedOperationsDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlowsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]", "terseLabel": "Discontinued Operations" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessOperatingNonCashItemsAndInvestingActivitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessResultsOfOperationsDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleOperatingNonCashItemsAndInvestingActivitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleResultsOfOperationsDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsTables" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": { "auth_ref": [ "r2", "r12", "r13", "r14", "r15", "r16", "r17", "r22", "r25", "r26", "r27", "r256", "r257" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessOperatingNonCashItemsAndInvestingActivitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessResultsOfOperationsDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleOperatingNonCashItemsAndInvestingActivitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleResultsOfOperationsDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsTables" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r253", "r260" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r260" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r123", "r439", "r440", "r442", "r445", "r447", "r450", "r451", "r452" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureIncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r124", "r142", "r143", "r189", "r437", "r446", "r448", "r575" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 }, "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Income tax (benefit) expense" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureIncomeTaxesDetails", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r113" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Cash paid for taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r109" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r109" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable, net" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r109" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "verboseLabel": "Changes in operating assets and liabilities, net of effect of divestiture:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.", "label": "Increase (Decrease) in Other Noncurrent Liabilities", "terseLabel": "Other long-term liabilities" } } }, "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r109" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r109" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r236", "r241" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r92", "r311", "r323", "r326", "r327" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest Expense, Debt", "verboseLabel": "Interest expense" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleSeniorSubordinatedNotesDetails", "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLineOfCreditDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebtExcludingAmortization": { "auth_ref": [ "r94", "r312", "r326", "r327" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.", "label": "Interest Expense, Debt, Excluding Amortization", "terseLabel": "Paid or accrued interest" } } }, "localname": "InterestExpenseDebtExcludingAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleSeniorSubordinatedNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r558" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 }, "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest Income (Expense), Net", "negatedLabel": "Interest expense, net" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidCapitalized": { "auth_ref": [ "r96", "r113" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest capitalized, classified as investing activity.", "label": "Interest Paid, Capitalized, Investing Activities", "verboseLabel": "Interest costs capitalized to software development costs" } } }, "localname": "InterestPaidCapitalized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r104", "r107", "r113" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Net", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleSeniorSubordinatedNotesDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r62" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureAccruedExpensesAndOtherLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Interest Payable, Current", "terseLabel": "Interest", "verboseLabel": "Accrued interest payable" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureAccruedExpensesAndOtherLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleSeniorSubordinatedNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r31", "r54", "r528" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r61", "r122", "r199", "r220", "r274", "r275", "r276", "r279", "r280", "r281", "r283", "r285", "r287", "r288", "r464", "r468", "r469", "r499", "r526", "r527" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r52", "r122", "r220", "r499", "r528", "r550", "r566" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders' equity (deficit)" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, redeemable convertible preferred stock and stockholder's equity (deficit)", "verboseLabel": "Liabilities and stockholders' equity (deficit)" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r34", "r63", "r122", "r220", "r274", "r275", "r276", "r279", "r280", "r281", "r283", "r285", "r287", "r288", "r464", "r468", "r469", "r499", "r526", "r527", "r528" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "auth_ref": [ "r1", "r2", "r21", "r23", "r27", "r250", "r254" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current", "terseLabel": "Current liabilities of discontinued operations", "totalLabel": "Total current liabilities of discontinued operations" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current [Abstract]", "terseLabel": "Current liabilities of discontinued operations" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent": { "auth_ref": [ "r1", "r2", "r21", "r23", "r27", "r248", "r254" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent", "terseLabel": "Noncurrent liabilities of discontinued operations", "totalLabel": "Total noncurrent liabilities of discontinued operations" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent [Abstract]", "terseLabel": "Noncurrent liabilities of discontinued operations" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessAssetsAndLiabilitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Line of Credit Facility [Abstract]", "terseLabel": "Lines of Credit" } } }, "localname": "LineOfCreditFacilityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLineOfCreditDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.", "label": "Line of Credit Facility, Commitment Fee Percentage", "terseLabel": "Commitment fee at closing (as a percent)" } } }, "localname": "LineOfCreditFacilityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLineOfCreditDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r59" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLineOfCreditDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LondonInterbankOfferedRateLIBORMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.", "label": "LIBOR" } } }, "localname": "LondonInterbankOfferedRateLIBORMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLineOfCreditDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r42", "r304", "r320", "r324", "r325", "r549", "r564" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLongTermDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.", "label": "Long-term Debt", "terseLabel": "Long term debt, net", "totalLabel": "Total long-term debt, net" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleSeniorSubordinatedNotesDetails", "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermLineOfCredit": { "auth_ref": [ "r66", "r272", "r273" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-term Line of Credit, Noncurrent", "terseLabel": "Line of credit" } } }, "localname": "LongTermLineOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermPurchaseCommitmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Long-term Purchase Commitment [Line Items]", "terseLabel": "Purchase Agreements" } } }, "localname": "LongTermPurchaseCommitmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureCommitmentsAndContingenciesVendorPurchaseAgreementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermPurchaseCommitmentTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule setting forth key provisions of an arrangement under which the entity has agreed to purchase goods or services over a period of time greater than one year or the normal operating cycle, if longer, including the item for which expenditures will be made, minimum quantities, milestones, time period and committed amount.", "label": "Long-term Purchase Commitment [Table]" } } }, "localname": "LongTermPurchaseCommitmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureCommitmentsAndContingenciesVendorPurchaseAgreementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermPurchaseCommitmentPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period covered by the long-term purchase commitment, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Long-term Purchase Commitment, Period", "terseLabel": "Purchase obligation period" } } }, "localname": "LongtermPurchaseCommitmentPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureCommitmentsAndContingenciesVendorPurchaseAgreementsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r170", "r177" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "Nature of Operations [Text Block]", "terseLabel": "Nature of Business" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureNatureOfBusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r106" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash (used in) provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r106" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r106", "r108", "r111" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r27", "r76", "r77", "r80", "r83", "r111", "r122", "r134", "r136", "r137", "r138", "r139", "r142", "r143", "r155", "r191", "r197", "r201", "r204", "r207", "r220", "r274", "r275", "r276", "r279", "r280", "r281", "r283", "r285", "r287", "r288", "r484", "r499", "r556", "r571" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net loss", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Attributable to Parent [Abstract]", "verboseLabel": "Numerator (basic and diluted):" } } }, "localname": "NetIncomeLossAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareEpsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r136", "r137", "r138", "r139", "r145", "r146", "r156", "r159", "r191", "r197", "r201", "r204", "r207" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareEpsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "Net loss, basic" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareEpsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "auth_ref": [ "r147", "r150", "r151", "r152", "r153", "r156", "r159" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareEpsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "totalLabel": "Net loss, diluted" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareEpsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic": { "auth_ref": [ "r146", "r159" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareEpsDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from continuing operations available to common shareholders.", "label": "Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic", "terseLabel": "Net loss from continuing operations, basic" } } }, "localname": "NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareEpsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted": { "auth_ref": [ "r147", "r151", "r152", "r153", "r159" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareEpsDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) from continuing operations available to common shareholders.", "label": "Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted", "terseLabel": "Net loss from continuing operations, diluted" } } }, "localname": "NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareEpsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareEpsDetails": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from discontinued operations available to common shareholders.", "label": "Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic", "terseLabel": "Net loss from discontinued operations, basic" } } }, "localname": "NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareEpsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareEpsDetails": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) from discontinued operations available to common shareholders.", "label": "Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Diluted", "terseLabel": "Net loss from discontinued operations, diluted" } } }, "localname": "NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareEpsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Pronouncement" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncompeteAgreementsMember": { "auth_ref": [ "r455" ], "lang": { "en-us": { "role": { "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.", "label": "Non-competition agreements" } } }, "localname": "NoncompeteAgreementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r91" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other expense, net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NontradeReceivablesCurrent": { "auth_ref": [ "r46" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureOtherCurrentAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The sum of amounts currently receivable other than from customers. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.", "label": "Nontrade Receivables, Current", "terseLabel": "Non-trade receivables" } } }, "localname": "NontradeReceivablesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableRelatedPartiesNoncurrent": { "auth_ref": [ "r67", "r125", "r520" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), payable to related parties, which are due after one year (or one business cycle).", "label": "Notes Payable, Related Parties, Noncurrent", "terseLabel": "Long-term debt - related party, net of discount of $1,299 and $0, respectively", "verboseLabel": "Convertible senior subordinated notes held by a significant stockholder" } } }, "localname": "NotesPayableRelatedPartiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRelatedPartyTransactionsDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [ "r179" ], "lang": { "en-us": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number of Operating Segments", "terseLabel": "Number of operating segment" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingRevenueDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r191", "r197", "r201", "r204", "r207" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Income (Loss) [Abstract]", "verboseLabel": "Operating expenses:" } } }, "localname": "OperatingIncomeLossAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r514" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Current operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r514" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Noncurrent operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r513" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r196", "r197", "r198", "r199", "r201", "r207" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingEbitdaDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OptionIndexedToIssuersEquityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Option Indexed to Issuer's Equity [Line Items]", "terseLabel": "Warrants and options indexed to Company's stock" } } }, "localname": "OptionIndexedToIssuersEquityLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleNoteHedgeAndWarrantTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OptionIndexedToIssuersEquityShares": { "auth_ref": [ "r478" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of shares that could be issued to net share settle a contract, if applicable. If a contract does not have a fixed or determinable maximum number of shares that may be required to be issued, disclose the fact that a potentially infinite number of shares could be issued to settle the contract.", "label": "Option Indexed to Issuer's Equity, Shares", "terseLabel": "Options indexed to Company's stock (in shares)" } } }, "localname": "OptionIndexedToIssuersEquityShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleNoteHedgeAndWarrantTransactionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_OptionIndexedToIssuersEquityStrikePrice1": { "auth_ref": [ "r329", "r477" ], "lang": { "en-us": { "role": { "documentation": "Exercise or strike price stated in the contract for options indexed to the issuer's equity shares.", "label": "Option Indexed to Issuer's Equity, Strike Price", "terseLabel": "Price of options indexed to Company's stock (in dollars per share)" } } }, "localname": "OptionIndexedToIssuersEquityStrikePrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleNoteHedgeAndWarrantTransactionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_OptionIndexedToIssuersEquityTable": { "auth_ref": [ "r330", "r475", "r476", "r479" ], "lang": { "en-us": { "role": { "documentation": "Freestanding contracts issued by an Entity that are indexed to, and potentially settled in, an Entity's own stock by the different attributes of these freestanding contracts, including the strike price, number of shares, and settlement dates.", "label": "Option Indexed to Issuer's Equity [Table]" } } }, "localname": "OptionIndexedToIssuersEquityTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleNoteHedgeAndWarrantTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OptionIndexedToIssuersEquityTypeAxis": { "auth_ref": [ "r330", "r475", "r476", "r479" ], "lang": { "en-us": { "role": { "documentation": "Information by type of freestanding contracts issued by an entity that are indexed to, and potentially settled in, an entity's own stock.", "label": "Option Indexed to Issuer's Equity, Type [Axis]" } } }, "localname": "OptionIndexedToIssuersEquityTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleNoteHedgeAndWarrantTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OptionIndexedToIssuersEquityTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of the type of freestanding contract issued by a Company that is indexed to, and potentially settled in, a Company's own stock. Specifically, the pertinent rights and privileges of the securities outstanding.", "label": "Option Indexed to Issuer's Equity, Type [Domain]" } } }, "localname": "OptionIndexedToIssuersEquityTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleNoteHedgeAndWarrantTransactionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nature of Business" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r56", "r528" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureOtherCurrentAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other current assets", "totalLabel": "Total other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureOtherCurrentAssetsDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsMember": { "auth_ref": [ "r472", "r474" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other assets.", "label": "Other assets" } } }, "localname": "OtherAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsCloudComputingArrangementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r38" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Other Commitments [Line Items]", "terseLabel": "Financing Arrangements" } } }, "localname": "OtherCommitmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsVendorFinancingArrangementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCommitmentsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about obligations resulting from other commitments.", "label": "Other Commitments [Table]" } } }, "localname": "OtherCommitmentsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsVendorFinancingArrangementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCurrentAssetsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other current assets.", "label": "Other Current Assets [Text Block]", "terseLabel": "Other Current Assets" } } }, "localname": "OtherCurrentAssetsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureOtherCurrentAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r62", "r528" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureAccruedExpensesAndOtherLiabilitiesDetails": { "order": 12.0, "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Current", "terseLabel": "Other expenses" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureAccruedExpensesAndOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r68" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other long-term liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r111" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income (Expense)", "negatedLabel": "Other noncash items" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r93" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "terseLabel": "Other income" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other income (expense):" } } }, "localname": "OtherNonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": { "auth_ref": [ "r102" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.", "label": "Payments Of Contingent Consideration", "negatedLabel": "Payments of acquisition-related contingent consideration" } } }, "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfFinancingCosts": { "auth_ref": [ "r103" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for loan and debt issuance costs.", "label": "Payments of Financing Costs", "negatedLabel": "Payments for debt financing costs" } } }, "localname": "PaymentsOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r99" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payments Related to Tax Withholding for Share-based Compensation", "negatedLabel": "Payments for employee taxes for shares withheld" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r96" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchases of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToDevelopSoftware": { "auth_ref": [ "r96" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the development or modification of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.", "label": "Payments to Develop Software", "negatedLabel": "Software development costs" } } }, "localname": "PaymentsToDevelopSoftware", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PerformanceSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement awarded for meeting performance target.", "label": "Performance stock units" } } }, "localname": "PerformanceSharesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPerformanceBasedEquityAwardsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r390", "r391", "r392", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r403", "r404", "r405", "r406", "r407", "r408", "r410", "r411", "r413", "r414", "r416", "r417", "r418", "r419", "r420" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r390", "r391", "r392", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r403", "r404", "r405", "r406", "r407", "r408", "r410", "r411", "r413", "r414", "r416", "r417", "r418", "r419", "r420" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "auth_ref": [ "r492" ], "lang": { "en-us": { "role": { "documentation": "Measured at fair value for financial reporting purposes.", "label": "Portion at Fair Value Measurement [Member]" } } }, "localname": "PortionAtFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureFairValueMeasurementsFinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r44", "r331" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRightsPlanDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r44" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r44", "r331" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r44" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r44", "r528" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding at September 30, 2022 and December 31, 2021" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r32", "r55", "r223", "r224" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": { "auth_ref": [ "r95" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity.", "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested", "terseLabel": "Proceeds from sale of business", "verboseLabel": "Proceeds from divestiture of business" } } }, "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsHeldForSaleDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r97" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds from Issuance of Warrants", "terseLabel": "Proceeds from sale of warrants" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtConvertibleNoteHedgeAndWarrantTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLinesOfCredit": { "auth_ref": [ "r98", "r121" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Proceeds from Lines of Credit", "terseLabel": "Borrowings on line of credit" } } }, "localname": "ProceedsFromLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r97", "r428" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from stock options exercised (in dollars)", "verboseLabel": "Proceeds from exercise of stock options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsActivityDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductMember": { "auth_ref": [ "r363" ], "lang": { "en-us": { "role": { "documentation": "Article or substance produced by nature, labor or machinery.", "label": "Product" } } }, "localname": "ProductMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRevenueDisaggregationDetails", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingRevenueDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r27", "r76", "r77", "r80", "r105", "r122", "r134", "r142", "r143", "r191", "r197", "r201", "r204", "r207", "r220", "r274", "r275", "r276", "r279", "r280", "r281", "r283", "r285", "r287", "r288", "r462", "r465", "r466", "r470", "r471", "r484", "r499", "r559" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "verboseLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property and Equipment." } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r252" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosurePropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r258", "r596", "r597", "r598" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosurePropertyAndEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosurePropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r251" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosurePropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PurchaseObligation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.", "label": "Purchase Obligation", "terseLabel": "Minimum purchase obligation" } } }, "localname": "PurchaseObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureCommitmentsAndContingenciesVendorPurchaseAgreementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": { "auth_ref": [ "r197", "r201" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.", "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]", "terseLabel": "Schedules of reconciliation of net loss to Adjusted EBITDA" } } }, "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r379", "r519", "r520", "r523" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r379" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of selling, general and administrative expenses resulting from transactions, excluding transactions that are eliminated in consolidated or combined financial statements, with related party.", "label": "Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party", "terseLabel": "General and administrative expenses" } } }, "localname": "RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r517", "r518", "r520", "r524", "r525" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfLinesOfCredit": { "auth_ref": [ "r101", "r121" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Repayments of Lines of Credit", "negatedLabel": "Repayments of line of credit", "terseLabel": "Repayment of line of credit" } } }, "localname": "RepaymentsOfLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLineOfCreditDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities": { "auth_ref": [ "r100" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation.", "label": "Repayments of Long-term Debt, Long-term Capital Lease Obligations, and Capital Securities", "negatedLabel": "Repayments of long-term debt and finance leases" } } }, "localname": "RepaymentsOfLongTermDebtAndCapitalSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r434", "r541", "r602" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock": { "auth_ref": [ "r604" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.", "label": "Research, Development, and Computer Software Disclosure [Text Block]", "terseLabel": "Software Development Costs" } } }, "localname": "ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSoftwareDevelopmentCosts" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restricted Cash and Cash Equivalents [Abstract]", "terseLabel": "Reconciliation of cash and restricted cash:" } } }, "localname": "RestrictedCashAndCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlowsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r35", "r112", "r117" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlowsParenthetical": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash and Cash Equivalents, Current", "terseLabel": "Restricted cash", "verboseLabel": "Restricted cash" } } }, "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlowsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r160" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted stock" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationRestrictedCommonStockAndRestrictedStockUnitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted stock units" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationRestrictedCommonStockAndRestrictedStockUnitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r49", "r343", "r528", "r565", "r584", "r585" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r130", "r131", "r132", "r135", "r141", "r143", "r221", "r429", "r430", "r431", "r443", "r444", "r482", "r581", "r583" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue." } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r182", "r183", "r196", "r202", "r203", "r210", "r211", "r213", "r358", "r359", "r542" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Total revenue", "verboseLabel": "Total revenue" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRevenueDisaggregationDetails", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingRevenueDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerMember": { "auth_ref": [ "r174", "r213" ], "lang": { "en-us": { "role": { "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncementsConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r362", "r370" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRevenue" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromRelatedParties": { "auth_ref": [ "r87", "r277", "r279", "r280", "r286", "r287", "r288", "r587" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.", "label": "Revenue from Related Parties", "terseLabel": "Revenue from related party" } } }, "localname": "RevenueFromRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "terseLabel": "Revenue:" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r160" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareAntiDilutiveSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r160" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Schedule of shares excluded from the calculation of diluted net loss per share attributable to common stockholders" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r66", "r128", "r324", "r326", "r338", "r340", "r341", "r342", "r508", "r509", "r512", "r560" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-term Debt Instruments [Table Text Block]", "verboseLabel": "Schedule of long-term debt obligations" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": { "auth_ref": [ "r2", "r12", "r13", "r14", "r15", "r16", "r17", "r22", "r25", "r26", "r27", "r256", "r257" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]", "terseLabel": "Schedules of discontinued operations" } } }, "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r159" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "verboseLabel": "Schedule of calculation of basic and diluted net loss per share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r421", "r432" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r421" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]", "terseLabel": "Schedule of recorded stock-based compensation expense related to stock options" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r238", "r242", "r543" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r238", "r242" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of intangible assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amounts of other current assets.", "label": "Schedule of Other Current Assets [Table Text Block]", "terseLabel": "Schedule of Other Current Assets" } } }, "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureOtherCurrentAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r252" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosurePropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r521", "r523" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r191", "r194", "r200", "r234" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingEbitdaDetails", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaLossDiscontinuedOperationsDetails", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r191", "r194", "r200", "r234" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of reportable operating segment information" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r386", "r387", "r390", "r391", "r392", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r403", "r404", "r405", "r406", "r407", "r408", "r410", "r411", "r413", "r414", "r416", "r417", "r418", "r419", "r420" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationEmployeeStockPurchasePlanDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsActivityDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsValuationDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOtherStockAwardsDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPerformanceBasedEquityAwardsDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPlansDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationRestrictedCommonStockAndRestrictedStockUnitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "auth_ref": [ "r393" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.", "label": "Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]", "terseLabel": "Summary of restricted stock award activity" } } }, "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r393", "r409", "r412" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]", "terseLabel": "Summary of stock option activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r415" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Schedule of weighted average assumptions for employee grants" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r242" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Schedule of estimated amortization expense" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDiscontinuedOperationsMember": { "auth_ref": [ "r3", "r6", "r7", "r8" ], "lang": { "en-us": { "role": { "documentation": "Component or group of components disposed of or classified as held-for-sale and representing a strategic shift that has or will have a major effect on operations and financial results. Includes a business or nonprofit activity on acquisition classified as held-for-sale.", "label": "Discontinued Operations, Held-for-sale or Disposed of by Sale" } } }, "localname": "SegmentDiscontinuedOperationsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessOperatingNonCashItemsAndInvestingActivitiesDetails", "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessResultsOfOperationsDetails", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaLossDiscontinuedOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r178", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r196", "r197", "r198", "r199", "r201", "r202", "r203", "r204", "r205", "r207", "r213", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r261", "r262", "r576" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRevenueDisaggregationDetails", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingEbitdaDetails", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r178", "r180", "r181", "r191", "r195", "r201", "r205", "r206", "r207", "r208", "r210", "r212", "r213", "r214" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Segment Reporting" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSegmentReporting" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingEbitdaDetails", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaLossDiscontinuedOperationsDetails", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling and Marketing Expense", "terseLabel": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingAndMarketingExpenseMember": { "auth_ref": [ "r85" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling and marketing expense.", "label": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ServiceMember": { "auth_ref": [ "r363" ], "lang": { "en-us": { "role": { "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.", "label": "Service" } } }, "localname": "ServiceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRevenueDisaggregationDetails", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingRevenueDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_SeveranceCosts1": { "auth_ref": [ "r110" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails": { "order": 6.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.", "label": "Severance Costs", "terseLabel": "Severance costs" } } }, "localname": "SeveranceCosts1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingReconciliationOfNetLossToAdjustedEbitdaDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r390" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPerformanceBasedEquityAwardsDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationRestrictedCommonStockAndRestrictedStockUnitsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r408" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedLabel": "Forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationRestrictedCommonStockAndRestrictedStockUnitsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r408" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationRestrictedCommonStockAndRestrictedStockUnitsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPerformanceBasedEquityAwardsDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationRestrictedCommonStockAndRestrictedStockUnitsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Granted (in dollars per share)", "verboseLabel": "Weighted average grant-date fair value (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOtherStockAwardsDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPerformanceBasedEquityAwardsDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationRestrictedCommonStockAndRestrictedStockUnitsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r403", "r404" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Outstanding at end of period (in shares)", "periodStartLabel": "Outstanding at beginning of period (in shares)", "verboseLabel": "Number of target shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPerformanceBasedEquityAwardsDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationRestrictedCommonStockAndRestrictedStockUnitsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Number of shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationRestrictedCommonStockAndRestrictedStockUnitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r403", "r404" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Outstanding at end of period (in dollars per share)", "periodStartLabel": "Outstanding at beginning of period (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationRestrictedCommonStockAndRestrictedStockUnitsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted average grant date fair value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationRestrictedCommonStockAndRestrictedStockUnitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r407" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedLabel": "Vested (in shares)", "terseLabel": "Vested (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPerformanceBasedEquityAwardsDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationRestrictedCommonStockAndRestrictedStockUnitsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r407" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "verboseLabel": "Vested (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationRestrictedCommonStockAndRestrictedStockUnitsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]", "terseLabel": "Valuation assumptions:" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsValuationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r417" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Expected volatility (as a percent)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsValuationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r419" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk-free interest rate (as a percent)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsValuationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Stock-Based Compensation" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationEmployeeStockPurchasePlanDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsActivityDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsValuationDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOtherStockAwardsDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPerformanceBasedEquityAwardsDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPlansDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationRestrictedCommonStockAndRestrictedStockUnitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "documentation": "Number of shares under non-option equity instrument agreements for which rights to exercise lapsed.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations", "terseLabel": "Expired (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPerformanceBasedEquityAwardsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized", "terseLabel": "Additional shares authorized" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPlansDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r427" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant", "terseLabel": "Available for future grant (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPlansDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r396" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number", "terseLabel": "Exercisable at end of period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r396" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Exercisable at end of period (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "auth_ref": [ "r411" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value", "terseLabel": "Intrinsic value of options exercised (in dollars)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r400" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r398" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross", "verboseLabel": "Options granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsValuationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r410" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average grant-date fair value (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsValuationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r427" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Outstanding (in dollars)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r394", "r395" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Outstanding at end of the period (in shares)", "periodStartLabel": "Outstanding at beginning of period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Number of shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r394", "r395" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Outstanding at end of period (in dollars per share)", "periodStartLabel": "Outstanding at beginning of period (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]", "terseLabel": "Weighted average exercise price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": { "auth_ref": [ "r413" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value", "terseLabel": "Options vested and expected to vest at end of period (in dollars)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": { "auth_ref": [ "r413" ], "lang": { "en-us": { "role": { "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number", "terseLabel": "Options vested and expected to vest at end of the period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r413" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price", "terseLabel": "Options vested and expected to vest at end of period (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum", "terseLabel": "Automatic increase on share reserve (as a percent)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPlansDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r390", "r391", "r392", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r403", "r404", "r405", "r406", "r407", "r408", "r410", "r411", "r413", "r414", "r416", "r417", "r418", "r419", "r420" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationEmployeeStockPurchasePlanDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsActivityDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsValuationDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOtherStockAwardsDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPerformanceBasedEquityAwardsDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationRestrictedCommonStockAndRestrictedStockUnitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r399" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Exercised (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r400" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "terseLabel": "Forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by supplier.", "label": "Supplier [Axis]" } } }, "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureCommitmentsAndContingenciesVendorPurchaseAgreementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Specific identification or general nature of (for example, a construction contractor, a consulting firm) the party from whom the goods or services were or are to be received.", "label": "Supplier [Domain]" } } }, "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureCommitmentsAndContingenciesVendorPurchaseAgreementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "auth_ref": [ "r390" ], "lang": { "en-us": { "role": { "documentation": "Percentage of vesting of award under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage", "terseLabel": "Vesting (as a percent)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPerformanceBasedEquityAwardsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected term (years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsValuationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r427" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value", "terseLabel": "Exercisable (in dollars)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r427" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r413" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Outstanding" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r413" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Options vested and expected to vest at of the period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance at end of period (in shares)", "periodStartLabel": "Balance at beginning of period (in shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Shares Paid for Tax Withholding for Share Based Compensation", "negatedLabel": "Shares withheld for payment of employee taxes (in shares)", "terseLabel": "Shares paid for tax withholding (in shares)" } } }, "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsActivityDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r118", "r129" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "verboseLabel": "Basis of Presentation, Summary of Significant Accounting Policies, and Recent Accounting Pronouncements" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureBasisOfPresentationSummaryOfSignificantAccountingPoliciesAndRecentAccountingPronouncements" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r11", "r178", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r196", "r197", "r198", "r199", "r201", "r202", "r203", "r204", "r205", "r207", "r213", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r255", "r261", "r262", "r576" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRevenueDisaggregationDetails", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingEbitdaDetails", "http://www.tabularasahealthcare.com/role/DisclosureSegmentReportingRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r43", "r44", "r45", "r120", "r122", "r148", "r149", "r154", "r157", "r159", "r167", "r168", "r169", "r220", "r274", "r279", "r280", "r281", "r287", "r288", "r331", "r332", "r335", "r336", "r337", "r499", "r610" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureRightsPlanDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r71", "r78", "r79", "r80", "r130", "r131", "r132", "r135", "r141", "r143", "r166", "r221", "r337", "r343", "r429", "r430", "r431", "r443", "r444", "r482", "r501", "r502", "r503", "r504", "r505", "r506", "r516", "r581", "r582", "r583" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlowsParenthetical", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF CASH FLOWS" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONSOLIDATED BALANCE SHEETS" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r130", "r131", "r132", "r166", "r542" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlowsParenthetical", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, before forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Stock Granted, Value, Share-based Compensation, Gross", "terseLabel": "Issuance of common stock awards" } } }, "localname": "StockGrantedDuringPeriodValueSharebasedCompensationGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited": { "auth_ref": [ "r44", "r45", "r337", "r343" ], "lang": { "en-us": { "role": { "documentation": "Number of shares related to Restricted Stock Award forfeited during the period.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Forfeited", "negatedLabel": "Forfeitures of restricted shares (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "auth_ref": [ "r337", "r343" ], "lang": { "en-us": { "role": { "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross", "terseLabel": "Issuance of restricted stock (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Stock Issued During Period, Shares, Share-based Compensation, Gross", "terseLabel": "Issuance of common stock awards (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOtherStockAwardsDetails", "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationPerformanceBasedEquityAwardsDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r44", "r45", "r337", "r343", "r399" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "negatedLabel": "Exercised (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureStockBasedCompensationOptionsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures": { "auth_ref": [ "r44", "r45", "r337", "r343" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Value of stock related to Restricted Stock Awards forfeited during the period.", "label": "Stock Issued During Period, Value, Restricted Stock Award, Forfeitures", "negatedLabel": "Forfeitures of restricted shares" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": { "auth_ref": [ "r44", "r45", "r337", "r343" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.", "label": "Stock Issued During Period, Value, Restricted Stock Award, Gross", "terseLabel": "Issuance of restricted stock" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r45", "r50", "r51", "r122", "r219", "r220", "r499", "r528" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance at end of period", "periodStartLabel": "Balance at beginning of period", "totalLabel": "Total stockholders' equity (deficit)" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "verboseLabel": "Stockholders' equity (deficit):" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r507", "r529" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event." } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlowsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r507", "r529" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlowsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r507", "r529" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfCashFlowsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_TaxesPayableCurrent": { "auth_ref": [ "r60" ], "calculation": { "http://www.tabularasahealthcare.com/role/DisclosureAccruedExpensesAndOtherLiabilitiesDetails": { "order": 11.0, "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Taxes Payable, Current", "terseLabel": "Income and non-income taxes payable" } } }, "localname": "TaxesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureAccruedExpensesAndOtherLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TradeNamesMember": { "auth_ref": [ "r454" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trade name" } } }, "localname": "TradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureGoodwillAndIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockCommonMember": { "auth_ref": [ "r344" ], "lang": { "en-us": { "role": { "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock" } } }, "localname": "TreasuryStockCommonMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockCommonShares": { "auth_ref": [ "r344" ], "lang": { "en-us": { "role": { "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common, Shares", "negatedPeriodEndLabel": "Balance at end of period, treasury stock (in shares)", "negatedPeriodStartLabel": "Balance at beginning of period, treasury stock (in shares)", "terseLabel": "Treasury stock (in shares)" } } }, "localname": "TreasuryStockCommonShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheetsParenthetical", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockCommonValue": { "auth_ref": [ "r72", "r344", "r345" ], "calculation": { "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common, Value", "negatedLabel": "Treasury stock, at cost; 885,862 and 369,802 shares at September 30, 2022 and December 31, 2021, respectively" } } }, "localname": "TreasuryStockCommonValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r460" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureDiscontinuedOperationsDivestitureOfBusinessDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r441" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Increase in valuation allowance", "terseLabel": "Increase (decrease) valuation allowance" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLineOfCreditDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureLineOfCreditAndLongTermDebtLineOfCreditDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants and Rights Note Disclosure [Abstract]" } } }, "localname": "WarrantsAndRightsNoteDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r147", "r159" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "verboseLabel": "Weighted average common shares outstanding, diluted (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareEpsDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Weighted average common shares outstanding:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r145", "r159" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "verboseLabel": "Weighted average common shares outstanding, basic (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.tabularasahealthcare.com/role/DisclosureNetLossPerShareEpsDetails", "http://www.tabularasahealthcare.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 9 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r129": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r165": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592" }, "r177": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r214": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org/topic&trid=2134510" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r247": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "https://asc.fasb.org/topic&trid=2144416" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2510-110228" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2473-110228" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230" }, "r258": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r265": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r271": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=d3e1314-112600" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=d3e1336-112600" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=26872618&loc=d3e7436-122677" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606" }, "r29": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/subtopic&trid=2122178" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721491-107759" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r328": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=109262807&loc=d3e22047-110879" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "63", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=126970277&loc=d3e23176-110880" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org/topic&trid=49130388" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(4)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r433": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r452": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6411-128476" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "b", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613673-111683" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90193-114008" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90198-114008" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(b)(2),(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "2E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL7498357-110258" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r525": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(20))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(11))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.1(c))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column B)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column C)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column D)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column E)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column F)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128487-111756" }, "r604": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "730", "Topic": "985", "URI": "https://asc.fasb.org/subtopic&trid=2197926" }, "r605": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r606": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r607": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r608": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r609": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r610": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r611": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(5))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.23)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721501-107759" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721503-107759" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(13))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868656-224227" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1(e))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.13)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "8", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" } }, "version": "2.1" }